P.2.b.013 Brain glucose transporters in an animal model of depression (English)
- New search for: Glombik, K.
- New search for: Detka, J.
- New search for: Dardzinska, A.
- New search for: Basta-Kaim, A.
- New search for: Leskiewicz, M.
- New search for: Regulska, M.
- New search for: Kubera, M.
- New search for: Lason, W.
- New search for: Budziszewska, B.
- New search for: Glombik, K.
- New search for: Detka, J.
- New search for: Dardzinska, A.
- New search for: Basta-Kaim, A.
- New search for: Leskiewicz, M.
- New search for: Regulska, M.
- New search for: Kubera, M.
- New search for: Lason, W.
- New search for: Budziszewska, B.
In:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
;
21
;
S375
;
2011
-
ISSN:
- Article (Journal) / Print
-
Title:P.2.b.013 Brain glucose transporters in an animal model of depression
-
Contributors:Glombik, K. ( author ) / Detka, J. ( author ) / Dardzinska, A. ( author ) / Basta-Kaim, A. ( author ) / Leskiewicz, M. ( author ) / Regulska, M. ( author ) / Kubera, M. ( author ) / Lason, W. ( author ) / Budziszewska, B. ( author )
-
Published in:EUROPEAN NEUROPSYCHOPHARMACOLOGY ; 21 ; S375
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2011-01-01
-
Size:S375
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.8 / 615.1
- Further information on Dewey Decimal Classification
-
Classification:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 21
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
NewMood: A productive European model of collaboration for translational research in depressionDeakin, J. F. / Harro, J. / Anderson, I. M. et al. | 2011
- 3
-
Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depressionHoyle, D. / Juhasz, G. / Aso, E. / Chase, D. / del Rio, J. / Fabre, V. / Hamon, M. / Lanfumey, L. / Lesch, K. P. / Maldonado, R. et al. | 2011
- 11
-
Genes differentially expressed in CB1 knockout mice: Involvement in the depressive-like phenotypeAso, E. / Ozaita, A. / Serra, M. A. / Maldonado, R. et al. | 2011
- 23
-
Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortexTordera, R. M. / Garcia-Garcia, A. L. / Elizalde, N. / Segura, V. / Aso, E. / Venzala, E. / Ramirez, M. J. / Del Rio, J. et al. | 2011
- 33
-
Differential gene expression in mutant mice overexpressing or deficient in the serotonin transporter: A focus on urocortin 1Fabre, V. / Massart, R. / Rachalski, A. / Jennings, K. / Brass, A. / Sharp, T. / Lesch, K. P. / Lanfumey, L. / Hamon, M. et al. | 2011
- 45
-
Effect of chronic mild stress on hippocampal transcriptome in mice selected for high and low stress-induced analgesia and displaying different emotional behaviorsLisowski, P. / Juszczak, G. R. / Goscik, J. / Wieczorek, M. / Zwierzchowski, L. / Swiergiel, A. H. et al. | 2011
- 63
-
Epistatic interaction of CREB1 and KCNJ6 on rumination and negative emotionalityLazary, J. / Juhasz, G. / Anderson, I. M. / Jacob, C. P. / Nguyen, T. T. / Lesch, K. P. / Reif, A. / Deakin, J. F. / Bagdy, G. et al. | 2011
- 71
-
Evidence of female-specific glial deficits in the hippocampus in a mouse model of prenatal stressBehan, A. T. / van den Hove, D. L. / Mueller, L. / Jetten, M. J. / Steinbusch, H. W. / Cotter, D. R. / Prickaerts, J. et al. | 2011
- 80
-
Enhanced hippocampal long-term potentiation following repeated MDMA treatment in Dark-Agouti ratsMorini, R. / Mlinar, B. / Baccini, G. / Corradetti, R. et al. | 2011
- 92
-
Brain responses to chronic social defeat stress: Effects on regional oxidative metabolism as a function of a hedonic trait, and gene expression in susceptible and resilient ratsKanarik, M. / Alttoa, A. / Matrov, D. / Koiv, K. / Sharp, T. / Panksepp, J. / Harro, J. et al. | 2011
- 108
-
Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout miceLine, S. J. / Barkus, C. / Coyle, C. / Jennings, K. A. / Deacon, R. M. / Lesch, K. P. / Sharp, T. / Bannerman, D. M. et al. | 2011
- 117
-
Cerebral metabolic responses to 5-HT2A/C receptor activation in mice with genetically modified serotonin transporter (SERT) expressionDawson, N. / Ferrington, L. / Lesch, K. P. / Kelly, P. A. et al. | 2011
- 129
-
The HTR1A and HTR1B receptor genes influence stress-related information processingMekli, K. / Payton, A. / Miyajima, F. / Platt, H. / Thomas, E. / Downey, D. / Lloyd-Williams, K. / Chase, D. / Toth, Z. G. / Elliott, R. et al. | 2011
- 140
-
The effect of acute citalopram on face emotion processing in remitted depression: A pharmacoMRI studyAnderson, I. M. / Juhasz, G. / Thomas, E. / Downey, D. / McKie, S. / Deakin, J. F. / Elliott, R. et al. | 2011
- 149
-
Contents| 2011
- 151
-
Costs of illness and care in Parkinson's diseaseKorczyn, A. D. et al. | 2011
- 153
-
An introduction to adaptive designs and adaptation in CNS trialsDragalin, V. et al. | 2011
- 159
-
Adaptive design clinical trials and trial logistics models in CNS drug developmentWang, S. J. / Hung, H. M. / O'Neill, R. et al. | 2011
- 167
-
ISCTM: Implementing phase 2 dose finding adaptive clinical trialsParke, T. et al. | 2011
- 175
-
Adaptive clinical trials for new drug applications in JapanAndo, Y. / Hirakawa, A. / Uyama, Y. et al. | 2011
- 180
-
Costs of illness and care in Parkinson's Disease: An evaluation in six countriesvon Campenhausen, S. / Winter, Y. / Rodrigues e Silva, A. / Sampaio, C. / Ruzicka, E. / Barone, P. / Poewe, W. / Guekht, A. / Mateus, C. / Pfeiffer, K. P. et al. | 2011
- 192
-
In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: Involvement of dopamine D1 and alpha 2 adrenergic receptorsGronier, B. et al. | 2011
- 205
-
Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in ratsCrunelle, C. L. / Schulz, S. / de Bruin, K. / Miller, M. L. / van den Brink, W. / Booij, J. et al. | 2011
- 211
-
Pregnenolone sulfate and its enantiomer: Differential modulation of memory in a spatial discrimination task using forebrain NMDA receptor deficient micePetit, G. H. / Tobin, C. / Krishnan, K. / Moricard, Y. / Covey, D. F. / Rondi-Reig, L. / Akwa, Y. et al. | 2011
- 216
-
Evidence for the modality independence of the genetic epistasis between the dopaminergic and cholinergic system on working memory capacityMarkett, S. / Montag, C. / Walter, N. T. / Reuter, M. et al. | 2011
- 221
-
A selective neurokinin-1 receptor antagonist in chronic PTSD: A randomized, double-blind, placebo-controlled, proof-of-concept trialMathew, S. J. / Vythilingam, M. / Murrough, J. W. / Zarate, C. A. / Feder, A. / Luckenbaugh, D. A. / Kinkead, B. / Parides, M. K. / Trist, D. G. / Bani, M. S. et al. | 2011
- 230
-
Early post-stressor intervention with propranolol is ineffective in preventing posttraumatic stress responses in an animal model for PTSDCohen, H. / Kaplan, Z. / Koresh, O. / Matar, M. A. / Geva, A. B. / Zohar, J. et al. | 2011
- 241
-
Early improvement in positive rather than negative emotion predicts remission from depression after pharmacotherapyGeschwind, N. / Nicolson, N. A. / Peeters, F. / van Os, J. / Barge-Schaapveld, D. / Wichers, M. et al. | 2011
- 248
-
Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information processingKlamer, D. / Svensson, L. / Fejgin, K. / Palsson, E. et al. | 2011
- 254
-
Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patientsBubber, P. / Hartounian, V. / Gibson, G. E. / Blass, J. P. et al. | 2011
- 261
-
Insulin receptor signaling in rat hippocampus: A study in STZ (ICV) induced memory deficit modelAgrawal, R. / Tyagi, E. / Shukla, R. / Nath, C. et al. | 2011
- 274
-
Leptin reduces hyperactivity in an animal model for anorexia nervosa via the ventral tegmental areaVerhagen, L. A. / Luijendijk, M. C. / Adan, R. A. et al. | 2011
- 282
-
Amisulpride vs. fluoxetine treatment of Chronic Fatigue Syndrome: A pilot studyPardini, M. / Guida, S. / Primavera, A. / Krueger, F. / Cocito, L. / Gialloreti, L. E. et al. | 2011
- 287
-
2-year course of bipolar disorder type I patients in outpatient care: Factors associated with remission and functional recoveryfor, t. E. / Haro, J. M. / Reed, C. / Gonzalez-Pinto, A. / Novick, D. / Bertsch, J. / Vieta, E. et al. | 2011
- 294
-
Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patientsGasso, P. / Mas, S. / Oliveira, C. / Bioque, M. / Parellada, E. / Bernardo, M. / Trias, G. / Comeche, J. / Lafuente, A. et al. | 2011
- 300
-
Effects of season of birth and a common MTHFR gene variant on the risk of schizophreniaGROUP, C. / Muntjewerff, J. W. / Ophoff, R. A. / Buizer-Voskamp, J. E. / Strengman, E. / den Heijer, M. et al. | 2011
- 306
-
Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviorsPobbe, R. L. / Zangrossi, H. / Blanchard, D. C. / Blanchard, R. J. et al. | 2011
- 316
-
GABAergic control of novelty stress-responsive epigenetic and gene expression mechanisms in the rat dentate gyrusPapadopoulos, A. / Chandramohan, Y. / Collins, A. / Droste, S. K. / Nutt, D. J. / Reul, J. M. et al. | 2011
- 325
-
Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepamLeggio, G. M. / Micale, V. / Le Foll, B. / Mazzola, C. / Nobrega, J. N. / Drago, F. et al. | 2011
- 333
-
Activation of a7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: Implications for therapy of cognitive dysfunction in schizophreniaMcLean, S. L. / Grayson, B. / Idris, N. F. / Lesage, A. S. / Pemberton, D. J. / Mackie, C. / Neill, J. C. et al. | 2011
- 344
-
Mapping of CBV changes in 5-HT1A terminal fields by functional MRI in the mouse brainMueggler, T. / Razoux, F. / Russig, H. / Buehler, A. / Franklin, T. B. / Baltes, C. / Mansuy, I. M. / Rudin, M. et al. | 2011
- 355
-
Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: Deregulation in schizophreniaDresner, E. / Agam, G. / Gozes, I. et al. | 2011
- 362
-
Factors associated with initial treatment response with antidepressants in bipolar disorderPacchiarotti, I. / Valenti, M. / Bonnin, C. M. / Rosa, A. R. / Murru, A. / Kotzalidis, G. D. / Nivoli, A. M. / Sanchez-Moreno, J. / Vieta, E. / Colom, F. et al. | 2011
- 370
-
Predictors of response and remission in the acute treatment of first-episode schizophrenia patients - Is it all about early response?Schennach-Wolff, R. / Jager, M. / Mayr, A. / Meyer, S. / Kuhn, K. U. / Klingberg, S. / Heuser, I. / Klosterkotter, J. / Gastpar, M. / Schmitt, A. et al. | 2011
- 379
-
Emotional processing as a predictor of symptom change: An acute tryptophan depletion study in depressed patientsBooij, L. / Van der Does, A. J. et al. | 2011
- 384
-
Acute and chronic suppression of the central ghrelin signaling system reveals a role in food anticipatory activityVerhagen, L. A. / Egecioglu, E. / Luijendijk, M. C. / Hillebrand, J. J. / Adan, R. A. / Dickson, S. L. et al. | 2011
- 393
-
Deep brain stimulation of the subthalamic or entopeduncular nucleus attenuates vacuous chewing movements in a rodent model of tardive dyskinesiaCreed, M. / Hamani, C. / Nobrega, J. N. et al. | 2011
- 401
-
Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in miceSinger, P. / Boison, D. / Mohler, H. / Feldon, J. / Yee, B. K. et al. | 2011
- 414
-
Effects of voluntary ethanol consumption on emotional state and stress responsiveness in socially isolated ratsPisu, M. G. / Mostallino, M. C. / Dore, R. / Maciocco, E. / Secci, P. P. / Serra, M. et al. | 2011
- 427
-
Antipsychotics in anxiety disorders: An oxymoron or a reflection of non-adequate nomenclature?Zohar, J. / Allgulander, C. et al. | 2011
- 429
-
Review of atypical antipsychotics in anxietyVulink, N. C. / Figee, M. / Denys, D. et al. | 2011
- 450
-
Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidityCaputo, F. / Francini, S. / Brambilla, R. / Vigna-Taglianti, F. / Stoppo, M. / Del Re, A. / Leggio, L. / Addolorato, G. / Zoli, G. / Bernardi, M. et al. | 2011
- 457
-
Differential effects of etifoxine on anxiety-like behaviour and convulsions in BALB/cByJ and C57BL/6J mice: Any relation to overexpression of central GABAA receptor beta2 subunits?Verleye, M. / Dumas, S. / Heulard, I. / Krafft, N. / Gillardin, J. M. et al. | 2011
- 471
-
Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administrationMoller, M. / Du Preez, J. L. / Emsley, R. / Harvey, B. H. et al. | 2011
- 484
-
Neurokinin3-R agonism in aged rats has anxiolytic-, antidepressant-, and promnestic-like effects and stimulates ACh release in frontal cortex, amygdala and hippocampusSchable, S. / Topic, B. / Buddenberg, T. / Petri, D. / Huston, J. P. / de Souza Silva, M. A. et al. | 2011
- 495
-
ECNP Summit on the future of CNS drug research in Europe 2011: Report prepared for ECNP by David Nutt and Guy GoodwinNutt, D. / Goodwin, G. et al. | 2011
- 500
-
Insomnia medication: Do published studies reflect the complete picture of efficacy and safety?Mattila, T. / Stoyanova, V. / Elferink, A. / Gispen-de Wied, C. / de Boer, A. / Wohlfarth, T. et al. | 2011
- 508
-
Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHDBiederman, J. / Mick, E. / Fried, R. / Wilner, N. / Spencer, T. J. / Faraone, S. V. et al. | 2011
- 516
-
(Don't) panic in the scanner! How panic patients with agoraphobia experience a functional magnetic resonance imaging sessionLueken, U. / Muehlhan, M. / Wittchen, H. U. / Kellermann, T. / Reinhardt, I. / Konrad, C. / Lang, T. / Wittmann, A. / Strohle, A. / Gerlach, A. L. et al. | 2011
- 526
-
The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in ratsHolly, E. N. / Ebrecht, B. / Prus, A. J. et al. | 2011
- 532
-
Advances in multidisciplinary and cross-species approaches to examine the neurobiology of psychiatric disordersKas, M. J. / Krishnan, V. / Gould, T. D. / Collier, D. A. / Olivier, B. / Lesch, K. P. / Domenici, E. / Fuchs, E. / Gross, C. / Castren, E. et al. | 2011
- 545
-
Nortriptyline influences protein pathways involved in carbohydrate metabolism and actin-related processes in a rat gene-environment model of depressionPiubelli, C. / Gruber, S. / El Khoury, A. / Mathe, A. A. / Domenici, E. / Carboni, L. et al. | 2011
- 563
-
Child and adolescent neuropsychopharmacology: Now or neverArango, C. et al. | 2011
- 565
-
The EU paediatric regulationStoyanova-Beninska, V. V. / Wohlfarth, T. / Isaac, M. / Kalverdijk, L. J. / van den Berg, H. / Gispen-de Wied, C. et al. | 2011
- 571
-
Pragmatic measures in paediatric psychopharmacology - Are we getting it right?Coghill, D. et al. | 2011
- 584
-
To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?van de Loo-Neus, G. H. / Rommelse, N. / Buitelaar, J. K. et al. | 2011
- 600
-
Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studiesZuddas, A. / Zanni, R. / Usala, T. et al. | 2011
- 621
-
Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisonsFraguas, D. / Correll, C. U. / Merchan-Naranjo, J. / Rapado-Castro, M. / Parellada, M. / Moreno, C. / Arango, C. et al. | 2011
- 646
-
Childhood methylphenidate treatment of ADHD and response to affective stimuliSchlochtermeier, L. / Stoy, M. / Schlagenhauf, F. / Wrase, J. / Park, S. Q. / Friedel, E. / Huss, M. / Lehmkuhl, U. / Heinz, A. / Strohle, A. et al. | 2011
- 655
-
The size and burden of mental disorders and other disorders of the brain in Europe 2010Wittchen, H. U. / Jacobi, F. / Rehm, J. / Gustavsson, A. / Svensson, M. / Jonsson, B. / Olesen, J. / Allgulander, C. / Alonso, J. / Faravelli, C. et al. | 2011
- 680
-
What we know and what we don't know about the treatment of schizoaffective disorderMurru, A. / Pacchiarotti, I. / Nivoli, A. M. / Grande, I. / Colom, F. / Vieta, E. et al. | 2011
- 691
-
Antidepressant use and salivary cortisol in depressive and anxiety disordersManthey, L. / Leeds, C. / Giltay, E. J. / van Veen, T. / Vreeburg, S. A. / Penninx, B. W. / Zitman, F. G. et al. | 2011
- 700
-
Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteersAndreou, D. / Saetre, P. / Kahler, A. K. / Werge, T. / Andreassen, O. A. / Agartz, I. / Sedvall, G. C. / Hall, H. / Terenius, L. / Jonsson, E. G. et al. | 2011
- 705
-
Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a b-substituted phenylethylamine in miceDhir, A. / Malik, S. / Kessar, S. V. / Singh, K. N. / Kulkarni, S. K. et al. | 2011
- 715
-
The full cost and burden of disorders of the brain in Europe exposed for the first timeNutt, D. J. et al. | 2011
- 718
-
Cost of disorders of the brain in Europe 2010on behalf, o. t. / Gustavsson, A. / Svensson, M. / Jacobi, F. / Allgulander, C. / Alonso, J. / Beghi, E. / Dodel, R. / Ekman, M. / Faravelli, C. et al. | 2011
- 781
-
Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden - Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trialsIsaac, M. / Vamvakas, S. / Abadie, E. / Jonsson, B. / Gispen, C. / Pani, L. et al. | 2011
- 789
-
When endocrinology and democracy collide: Emotions, cortisol and voting at national electionsWaismel-Manor, I. / Ifergane, G. / Cohen, H. et al. | 2011
- 796
-
High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: Interplay between clinical and animal studiesZohar, J. / Yahalom, H. / Kozlovsky, N. / Cwikel-Hamzany, S. / Matar, M. A. / Kaplan, Z. / Yehuda, R. / Cohen, H. et al. | 2011
- 810
-
Defensive self-presentation style is associated with reduced prepulse inhibitionLevin, R. / Bachner-Melman, R. / Lichtenberg, P. / Edelman, S. / Ebstein, R. P. / Heresco-Levy, U. et al. | 2011
- 814
-
Video telemetry and behavioral analysis discriminate between compulsive cleaning and compulsive checking in obsessive-compulsive disorderZor, R. / Fineberg, N. / Eilam, D. / Hermesh, H. et al. | 2011
- 825
-
Roles of BDNF, dopamine D3 receptors, and their interactions in the expression of morphine-induced context-specific locomotor sensitizationLiang, J. / Zheng, X. / Chen, J. / Li, Y. / Xing, X. / Bai, Y. et al. | 2011
- 835
-
Sequential and opposing alterations of 5-HT1A receptor function during withdrawal from chronic morphineLutz, P. E. / Pradhan, A. A. / Goeldner, C. / Kieffer, B. L. et al. | 2011
- 841
-
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidenceSarris, J. / Panossian, A. / Schweitzer, I. / Stough, C. / Scholey, A. et al. | 2011
- 861
-
Density of striatal D2 receptors in untreated first-episode psychosis: An I^1^2^3-IBZM SPECT studyCorripio, I. / Escarti, M. J. / Portella, M. J. / Perez, V. / Grasa, E. / Sauras, R. B. / Alonso, A. / Safont, G. / Camacho, M. V. / Duenas, R. et al. | 2011
- 867
-
Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: Findings from the CLAMORS studyArango, C. / Bobes, J. / Kirkpatrick, B. / Garcia-Garcia, M. / Rejas, J. et al. | 2011
- 876
-
High prevalence of obsessive-compulsive disorder among posttraumatic stress disorder patientsNacasch, N. / Fostick, L. / Zohar, J. et al. | 2011
- 880
-
Neural hyperactivation in carriers of the Alzheimer's risk variant on the clusterin geneLancaster, T. M. / Baird, A. / Wolf, C. / Jackson, M. C. / Johnston, S. J. / Donev, R. / Thome, J. / Linden, D. E. et al. | 2011
- 885
-
Effects of age on dopamine D2 receptor availability in striatal subdivisions: A high-resolution positron emission tomography studyKim, J. H. / Son, Y. D. / Kim, H. K. / Lee, S. Y. / Cho, S. E. / Kim, Y. B. / Cho, Z. H. et al. | 2011
- 892
-
Erk activation in the amygdala and hippocampus induced by fear conditioning in ethanol withdrawn rats: Modulation by mk-801Bertotto, M. E. / Maldonado, N. M. / Bignante, E. A. / Gorosito, S. V. / Cambiasso, M. J. / Molina, V. A. / Martijena, I. D. et al. | 2011
- 905
-
Involvement of the neurotrophin and cannabinoid systems in the mechanisms of action of neurokinin receptor antagonistsHassanzadeh, P. / Hassanzadeh, A. et al. | 2011
- 918
-
Effects of olanzapine on extracellular concentrations and tissue content of neurotensin in rat brain regionsGruber, S. H. / Angelucci, F. / Nomikos, G. G. / Mathe, A. A. et al. | 2011
- S1
-
S.1.01 Whole genome scansKelsoe, J. et al. | 2011
- S2
-
P.1.001 Chronic mild stress modulates the transcription of BDNF isoforms with brain region specificity: influence of antidepressant treatmentGuidotti, G. / Calabrese, F. / Molteni, R. / Macchi, F. / Racagni, G. / Riva, M. A. et al. | 2011
- S3
-
P.1.002 Drug interaction between fibrillar amyloid b and alpha7 nicotinic receptor in Alzheimer brainNi, R. / Marutle, A. / Nordberg, A. et al. | 2011
- S4
-
P.1.003 Multiple single nucleotide polymorphisms of schizophrenia-related DISC1 gene in lithium-treated patients with bipolar affective disorderCzerski, P. M. / Kliwicki, S. / Maciukiewicz, M. / Hauser, J. / Karlowski, W. / Cichon, S. / Rybakowski, J. K. et al. | 2011
- S5
-
P.1.005 Retinoic acid upregulates reduced cd38 transcription in lymphoblastoid cell lines from patients with autism spectrum disorderRiebold, M. / Mankuta, D. / Malavasi, F. / Lerer, E. / Levi, S. / Yirmiya, N. / Ebstein, R. P. et al. | 2011
- S6
-
P.1.006 Screening for rare variants in TMEM132D: a candidate gene from genome-wide association studies in anxiety disordersQuast, C. / Altmann, A. / Weber, P. / Rex-Haffner, M. / Erhardt, A. / Muller-Myhsok, B. / Binder, E. B. et al. | 2011
- S7
-
P.1.007 Assessment of cellular environments on radioligand binding - an application to opioid receptor PET imagingQuelch, D. R. / Tyacke, R. J. / Nutt, D. J. / Parker, C. A. et al. | 2011
- S8
-
P.1.008 The involvement of FK506-binding protein 51 gene (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stressHartmann, J. / Wagner, K. V. / Hausch, F. / Rein, T. / Schmidt, U. / Touma, C. / Muller, M. B. / Schmidt, M. V. et al. | 2011
- S9
-
P.1.009 Persistent changes in hippocampal glutamate receptor expression and depressive symptoms in mice after single treatment with ketamineRao, P. / van Bokhoven, P. / van der Loo, R. J. / Jansen, R. F. / Stiedl, O. / Smit, A. B. / Spijker, S. et al. | 2011
- S10
-
P.1.011 Evidence of hypothalamic mitochondrial dysfunction and neurodegeneration in the anorectic anx/anx mouse modelNilsson, I. A. / Lindfors, C. / Thams, S. / Garcia-Roves, P. M. / Cullheim, S. / Schalling, M. / Hokfelt, T. / Johansen, J. E. et al. | 2011
- S11
-
P.1.012 Changes in hippocampal plasticity during pregnancy and post partum are reversed by offspring separationSecci, P. / Mostallino, M. C. / Mura, M. L. / Talani, G. / Sanna, E. / Biggio, G. et al. | 2011
- S12
-
P.1.013 The cannabinoid-1 receptor antagonist rimonabant increases striatal dopamine D2/3 receptor availability in ratsvan de Giessen, E. / Crunelle, C. / Schulz, S. / Vanderschuren, L. / de Bruin, K. / van den Brink, W. / Booij, J. et al. | 2011
- S13
-
P.1.014 Time-dependent alterations of the endocannabinoid system and synaptic markers following adolescent delta-9-tetrahydrocannabinol (THC) administration in female ratsZamberletti, E. / Prini, P. / Gabaglio, M. / Rubino, T. / Parolaro, D. et al. | 2011
- S14
-
P.1.015 GluN2D-containing NMDA receptors in cholinergic interneurons control dopamine release in the mouse striatumZhang, X. / Chergui, K. et al. | 2011
- S15
-
P.1.017 Characterisation of the fast acting antidepressant LuAA21004: key role for the 5-HT3 receptor blockadeBetry, C. / Etievant, A. / Moore, N. / Ebert, B. / Sanchez, C. / Haddjeri, N. et al. | 2011
- S16
-
P.1.018 Glial modulation of medial prefrontal cortex deep brain stimulationEtievant, A. / Oosterhof, C. A. / Betry, C. / Abrial, E. / Lambas-Senas, L. / Scarna, H. / Lucas, G. / Haddjeri, N. et al. | 2011
- S17
-
P.1.019 Olanzapine-induced weight gain is associated with increased hypothalamic ghrelin receptor expressionSchellekens, H. / Davey, K. J. / OMahony, S. M. / Dinan, T. G. / Cryan, J. F. et al. | 2011
- S19
-
P.1.022 Epigenetic modifications in transgenic mouse with human polymorphism (Val66Met) of BDNF geneCorna, S. / Mallei, A. / Benevento, C. / Tardito, D. / Racagni, G. / Popoli, M. et al. | 2011
- S20
-
P.1.023 Influence of afobazol on neuromediator amino acids level in rat brain caused by global ischemiaBaykova, V. / Kadnikov, I. A. et al. | 2011
- S21
-
P.1.024 The epigenetic machinery of neural cells is modulated by psychoactive drugsZimmermann, N. / Perisic, T. / Hafner, K. / Uhr, M. / Holsboer, F. / Zschocke, J. / Rein, T. et al. | 2011
- S22
-
P.1.025 Stress at the synapse: the synaptic action of acute behavioural stress and the protective effect of psychiatric drugsTreccani, G. / Musazzi, L. / Milanese, M. / Farisello, P. / Mallei, A. / Perego, C. / Racagni, G. / Benfenati, F. / Bonanno, G. / Popoli, M. et al. | 2011
- S23
-
P.1.027 Modulation of the neurotrophin brain-derived neurotrophic factor in serotonin transporter mutant ratsMacchi, F. / Molteni, R. / Calabrese, F. / Cattaneo, A. / Racagni, G. / Ellenbroek, B. A. / Riva, M. A. et al. | 2011
- S24
-
P.1.030 Epigenetic modification of the glucocorticoid receptor gene predicts womens salivary cortisol following a threat to the social selfEdelman, S. / Shalev, I. / Uzefovsky, F. / Israel, S. / Knafo, A. / Mankuta, D. / Ebstein, R. P. et al. | 2011
- S25
-
P.1.031 Expression of glucose metabolism genes in a psychosis model: a molecular link between NMDA receptor hypofunction and metabolism disorders?Marmo, F. / Latte, G. / Avvisati, L. / Patri, A. / Rossi, R. / Buonaguro, E. F. / Tomasetti, C. / Iasevoli, F. / Aloj, L. / de Bartolomeis, A. et al. | 2011
- S26
-
P.1.032 Where and when ketamine alters the dopamine system: translational implications for drug addiction and psychosesCalandro, S. / Avvisati, L. / Latte, G. / Patri, A. / Rossi, R. / Buonaguro, E. F. / Sarappa, C. / Iasevoli, F. / Aloj, L. / de Bartolomeis, A. et al. | 2011
- S28
-
P.1.035 Finding gene expression regulators implicated in major depression using formaldehyde assisted isolation of regulatory elements (FAIRE)Paredes Esquivel, U. / Haddley, K. / Quinn, J. P. / Davidson, S. / MacKenzie, A. / McGuffin, P. / Breen, G. et al. | 2011
- S29
-
P.1.036 Antidepressants modulate human hippocampal neurogenesis by activating the glucocorticoid receptorAnacker, C. / Zunszain, P. A. / Cattaneo, A. / Carvalho, L. A. / Thuret, S. / Price, J. / Pariante, C. M. et al. | 2011
- S30
-
P.1.037 Brain regions involved in vulnerability to depression - an oxidative metabolism mapping approachKanarik, M. / Matrov, D. / Koiv, K. / Tordera, R. / Del Rio, J. / Harro, J. et al. | 2011
- S31
-
P.1.038 PARP, a chromatin structure modulator, attenuates consolidation of fear-associated memoriesElharrar, E. / Azulay, M. / Visochek, L. / Cohen-Armon, M. / Yadid, G. et al. | 2011
- S33
-
S.2.01 Integrated behavioural and physiological measures in fear learningStiedl, O. / Youn, J. / Hager, T. / Jansen, R. F. / Ogren, S. O. / Meyer, M. / ter Maat, A. / Gahr, M. et al. | 2011
- S34
-
S.2.02 Cortical and hippocampal regulation of amygdala-dependent emotionRessler, K. / Chhatwal, J. P. / Stanek, L. / Choi, D. C. / Heldt, S. A. et al. | 2011
- S35
-
P.2.001 Memantine rescues behavioural and cognitive deficits following olfactory bulbectomy in ratsBorre, Y. / Bosman, E. / Lemstra, S. / Olivier, B. / Oosting, R. S. et al. | 2011
- S36
-
P.2.002 1,2,3,4-Tetrahydroisoquinoline shows antidepressant properties in the modified rat forced swimming testMozdzen, E. / Wasik, A. / Romanska, I. / Antkiewicz-Michaluk, L. et al. | 2011
- S38
-
P.2.006 Lesions of the ventral medial prefrontal cortex enhance contextual fear generalisation in C57BL6/J miceCourtin, J. / Herry, C. et al. | 2011
- S39
-
P.2.007 Lipolysaccharide-induced changes in brain stimulation reward: anhedonia or sickness behaviour?Prins, J. / van Heesch, F. / de Haan, L. / Krajnc, A. M. / Kenny, P. J. / Olivier, B. / Kraneveld, A. D. / Korte, S. M. et al. | 2011
- S40
-
P.2.008 Rotational behaviour and dopamine metabolism in 6-OHDA-lesioned rats treated with L-DOPA and the nitric oxide donor, molsidomineCzarnecka, A. / Lenda, T. / Konieczny, J. / Zapala, M. / Lorenc-Koci, E. et al. | 2011
- S41
-
P.2.009 Compulsive behaviour in mice during daily scheduled food availability mimics ethological measures of OCD ritualsde Haas, R. / Oppelaar, H. / Westenberg, H. G. / Kas, M. J. et al. | 2011
- S43
-
P.2.012 Pattern of self-administration can influence motivation for cocaine in ratsMartin-Garcia, E. / Deroche-Gamonet, V. et al. | 2011
- S44
-
P.2.013 Reinforcing effects of cocaine in COMT knockout miceMus, L. V. / Dravolina, O. A. / Bespalov, A. Y. / Kaenmaki, M. / Salminen, O. / Tuominen, R. K. / Mannisto, P. T. / Zvartau, E. E. et al. | 2011
- S45
-
P.2.014 Pharmacological characterisation of meta-chlorophenylpiperazine-induced ritualistic chewing behaviours in ratImre, G. / Liko, I. / Gyertyan, I. et al. | 2011
- S46
-
P.2.015 The contribution of GABAA receptor alpha subunits in the actions of benzodiazepines using stress-induced hyperthermia in ratsVinkers, C. H. / Mirza, N. / Olivier, B. et al. | 2011
- S47
-
P.2.017 Antinociceptive effects of intrathecally administered nociceptin/orphanin FQ receptor agonists in the rat tail flick testNovi, C. / Ruggieri, V. / Filaferro, M. / Vitale, G. / Guerrini, R. / Rizzi, A. / Calo, G. et al. | 2011
- S48
-
P.2.018 Behavioural and cognitive alterations of the young megencephaly (BALB/cByJ-Kv1.1 mceph/mceph) mouseHolst, S. / Aberg, E. / Eriksson, T. M. / Ogren, S. O. / Lavebratt, C. et al. | 2011
- S49
-
P.2.019 The role of brain-derived neurotrophic factor in the antidepressant effect of desipramine and electroconvulsive treatmentTaliaz, D. / Zangen, A. et al. | 2011
- S51
-
P.2.022 Effects of treatment with NMDA receptor antagonists on reactivated spatial memory and repeated learning in adult ratsSolovieva, O. A. / Proshin, A. T. / Storozheva, Z. I. / Sherstnev, V. V. et al. | 2011
- S52
-
P.2.023 In vivo microdialysis studies of brain dopamine, glutamate and GABA overflow during cocaine self-administration and its extinctionWydra, K. / Zaniewska, M. / Suder, A. / Dziubina, A. / Kowalska, K. / Golembiowska, K. / Fuxe, K. / Filip, M. et al. | 2011
- S53
-
P.2.024 Differential role of the GABA transporters in the regulation of extracellular concentrations of GABA in the rat hippocampusKersante, F. / Rowley, S. C. / Gutierrez Mecinas, M. / Reul, J. M. / Linthorst, A. C. et al. | 2011
- S54
-
P.2.025 Erasure of traumatic fear memory in mice by a combination of fluoxetine and fear extinction trainingLindholm, J. / Karpova, N. N. / Castren, E. et al. | 2011
- S56
-
P.2.028 Active and passive MDMA (`ecstasy') intake induces differential transcriptional changes in the mouse brainOrejarena, M. J. / Fernandez-Castillo, N. / Ribases, M. / Casas, M. / Robledo, P. / Maldonado, R. / Cormand, B. et al. | 2011
- S57
-
P.2.029 Olanzapine effects on hyperphagia are induced by enhanced histaminergic neurotransmissionRevsin, Y. / van der Zaal, E. / van Gestel, M. / Brans, M. / Adan, R. H. et al. | 2011
- S60
-
P.3.003 The effects of quetiapine on emotional processingRock, P. L. / Goodwin, G. M. / McTavish, S. F. / Harmer, C. J. et al. | 2011
- S61
-
P.3.004 Risk for adverse health outcome in antipsychotic-naive adolescents after 12 months of treatment with second-generation antipsychoticsPina-Camacho, L. / Merchan-Naranjo, J. / Garcia-Amador, M. / Fraguas, D. / Tapia, C. / Moreno, C. / Llorente, C. / Arango, C. et al. | 2011
- S62
-
P.3.005 N-Acetylcysteine changes glutamate levels in cocaine dependent subjects: an open label [1H] MRS studySchmaal, L. / Goudriaan, A. E. / Van den Brink, W. / Veltman, D. J. et al. | 2011
- S63
-
P.3.006 Substance use and regional grey matter volume in individuals at high risk of psychosisStone, J. M. / Bhattacharyya, S. / Barker, G. / McGuire, P. K. et al. | 2011
- S64
-
P.3.007 Intranasal administration of arginine vasopressin selectively reduces cognitive empathyUzefovsky, F. / Shalev, I. / Israel, S. / Knafo, A. / Ebstein, R. P. et al. | 2011
- S65
-
P.3.009 A principal component analysis of treatment patterns according to clinical features in a naturalistic cohort study of bipolar patientsNivoli, A. M. / Colom, F. / Pacchiarotti, I. / Murru, A. / Valenti, M. / Bonnin, C. M. / Sanchez-Moreno, J. / Vieta, E. et al. | 2011
- S66
-
P.3.010 Cognitive and motor impulsivity in acute cannabis and cocaine users: preliminary results of a placebo-controlled studyvan Wel, J. H. / Spronk, D. / Kuypers, K. P. / Theunissen, E. L. / Verkes, R. J. / Cools, R. / Ramaekers, J. G. et al. | 2011
- S67
-
P.3.011 Deep brain stimulation of the nucleus accumbens affects operant responding and consummatory behaviour in a location-specific mannervan der Plasse, G. / Schrama, R. / van Seters, S. / Westenberg, H. G. / Vanderschuren, L. J. et al. | 2011
- S68
-
P.3.012 The influence of hormone replacement therapy on the serotonin-1A receptor binding in postmenopausal womenKranz, G. / Hahn, A. / Ungersbock, J. / Kaufmann, U. / Stein, P. / Baldinger, P. / Mitterhauser, M. / Wadsak, W. / Kasper, S. / Lanzenberger, R. et al. | 2011
- S70
-
P.3.015 The determining factors of orbitofrontal cortex associated decision-making skills in alcohol dependenceAndo, B. / Szkaliczki, A. / Kurgyis, E. / Feher, A. / Juhasz, A. / Demeter, I. / Szikszay, P. / Janka, Z. / Almos, P. Z. et al. | 2011
- S71
-
P.3.016 Increased functional coupling between basal ganglia and cortical regions during resting state in remitted major depressive disorderKalcher, K. / Pail, G. / Huf, W. / Scharinger, C. / Boubela, R. / Windischberger, C. / Filzmoser, P. / Moser, E. / Kasper, S. / Pezawas, L. et al. | 2011
- S72
-
P.3.017 In vivo measurements of brain serotonergic markers and analysis of drug use profiles among recreational ecstasy and hallucinogen usersErritzoe, D. / Licht, C. L. / Christoffersen, M. V. / Knudsen, G. M. et al. | 2011
- S77
-
S.4.01 Molecular targets identificationHarro, J. et al. | 2011
- S78
-
P.4.001 Mechanism and behavioural consequences of agonist-induced upregulation of alpha 7 nicotinic acetylcholine receptor levels in the rat brainThomsen, M. S. / El-Sayed, M. / Christensen, D. Z. / Mikkelsen, J. D. et al. | 2011
- S79
-
P.4.002 Catechol-o-methyltransferase (COMT) influences dopamine metabolism outside of the prefrontal cortexLaatikainen, L. M. / Sharp, T. / Harrison, P. J. / Tunbridge, E. M. et al. | 2011
- S82
-
P.4.006 Expression of EGR1, EGR2 and EGR3 proteins in postmortem brain of schizophrenic subjectsGarcia-Bea, A. / Gabilondo, A. M. / Kurita, M. / Callado, L. F. / Gonzalez-Maeso, J. / Meana, J. J. et al. | 2011
- S83
-
P.4.007 Human schizophrenia and autism candidate gene neurexin1a regulates behavioural habituation in miceLaarakker, M. C. / Reinders, N. R. / Bruining, H. / Ophoff, R. A. / Kas, M. J. et al. | 2011
- S84
-
P.4.008 Impact of the functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR) on schizophrenia and verbal memoryLennertz, L. / Mossner, R. et al. | 2011
- S85
-
P.4.009 Schizophrenia endophenotypes and stress hyper-reactivity co-precipitate following adverse life events in genetically susceptible ratsDaskalakis, N. P. / Martens, G. J. / Cools, A. R. / de Kloet, E. R. et al. | 2011
- S86
-
P.4.010 A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypyKoychev, I. / McMullen, K. / Lees, J. / Grayson, L. / Schmechtig, A. / Dourish, C. / Wilkinson, L. / Williams, S. / Deakin, J. F. / Barkus, E. et al. | 2011
- S89
-
P.4.014 Targeting the alpha7 nicotinic receptor subtype to restore working memory deficits in rats following sub-chronic ketamine exposureRushforth, S. / Malcolm, E. L. / Smith, L. N. / Lesage, A. S. / Steckler, T. / Shoaib, M. et al. | 2011
- S90
-
P.4.015 Reboxetine augments the antipsychotic-like effect of quetiapine and enhances cortical dopamine output and NMDA-induced currentsBjorkholm, C. / Marcus, M. M. / Jardemark, K. / Schilstrom, B. / Svensson, T. H. et al. | 2011
- S91
-
P.4.016 Follow-up of schizophrenia genome-wide association studies implicates the MHC region in cognitionWalters, J. / ODonovan, M. C. / Giegling, I. / Rujescu, D. / Owen, M. J. et al. | 2011
- S92
-
P.4.017 Brain derived neurotrophic factor as a predictor of the cognition and prognosis in first episode psychosis after antipsychotic treatmentRuiz De Azua Garcia, S. / Barbeito Resa, S. / Ugarte Ugarte, A. / Vega Perez, P. / Martinez Cengotitabengoa, M. / Gonzalez Ortega, I. / de la Rosa Ruiz, I. / Gonzalez-Pinto, A. et al. | 2011
- S95
-
Author Index| 2011
- S99
-
Keyword Index| 2011
- S103
-
S.1.01 The opioid system and protracted abstinence to drugs of abuseBefort, K. et al. | 2011
- S104
-
S.1.02 Naltrexone for opiate dependence: oral, implantable, and injectableKrupitsky, E. et al. | 2011
- S105
-
S.1.03 Nicotine-opioid interactions: in vitro and in vivo studiesTuominen, R. K. / Talka, R. / Kivinummi, T. / Pakkanen, J. S. / Nuutinen, S. / Ahtee, L. / Piepponen, T. P. / Mannisto, P. T. / Salminen, O. et al. | 2011
- S106
-
S.1.05 Psychopharmacological strategy in the treatment of drug dependenceVinnikova, M. / Mokhnachev, S. O. et al. | 2011
- S108
-
S.2.04 Adherence to treatment in bipolar disordersGonzalez-Pinto, A. / De Azua, S. R. et al. | 2011
- S109
-
S.2.05 Psychoeducation and shared decision making as a way to reduce non-compliance in mental disordersLeucht, S. et al. | 2011
- S110
-
S.3.01 Biomarkers for anxiety disorders: proteomic and systems biology approachesTurck, C. W. / Landgraf, R. / Filiou, M. D. / Zhang, Y. / Webhofer, C. / Reckow, S. / Gormanns, P. / Ditzen, C. / Maccarrone, G. / Varadarajulu, J. et al. | 2011
- S111
-
S.3.02 Depression in females: difficulties in modelling and pharmacological studiesAvgustinovich, D. / Kovalenko, I. / Vishnivetskaya, G. / Fomina, M. et al. | 2011
- S112
-
S.3.03 Inter-individual differences in impulsivity and underlying neurobiologyDalley, J. W. et al. | 2011
- S113
-
S.3.05 Low positive affect, anxiety and depressionHarro, J. / Matrov, D. / Mallo, T. / Raudkivi, K. / Le Maitre, E. / Hokfelt, T. et al. | 2011
- S114
-
S.4.02 ADHD and bipolar disorder in children and adolescentsMoreno, C. et al. | 2011
- S115
-
S.4.05 Suicide prevention in patients with mood disorderRihmer, Z. et al. | 2011
- S117
-
P.1.002 Memory-stimulating effect of dehydroepiandrosterone: involvement of dopaminergic receptor systemsFedotova, J. / Ordayn, N. et al. | 2011
- S118
-
P.1.004 PLA2G4A and PTGS2 gene polymorphisms in schizophreniaFeher, A. / Juhasz, A. / Rimanoczy, A. / Galfi, M. / Szekeres, G. / Janka, Z. et al. | 2011
- S119
-
P.1.006 No association between promoter polymorphism of the MAOA gene and Alzheimers diseaseJuhasz, A. / Feher, A. / Rimanoczy, A. / Galfi, M. / Kalman, J. / Janka, Z. et al. | 2011
- S120
-
P.1.009 Effects of the novel antiparkinsonian drug hemantane on brain bioelectric activity in mice with parkinsonian syndromeKapitsa, I. / Nerobkova, L. N. / Kurakhmaeva, K. B. / Kokschenev, I. I. / Nepoklonov, A. V. / Valdman, E. A. / Voronina, T. A. et al. | 2011
- S122
-
P.1.012 The main proinflammatory cytokines in neuroimmune interactionsKovalenko, L. / Tallerova, A. V. / Alekseeva, S. V. / Durnev, A. D. / Seredenin, S. B. et al. | 2011
- S123
-
P.1.014 Vasopressin 1b receptor polymorphism is associated with bipolar disorderSzczepankiewicz, A. / Leszczynska-Rodziewicz, A. / Pawlak, J. / Dmitrzak-Weglarz, M. / Skibinska, M. / Wilkosc, M. / Twarowska-Hauser, J. et al. | 2011
- S124
-
P.1.016 Antiserotoninergic and cerebrovascular effects of combination of tropoxin and mexidolGorbunov, A. / Ganshina, T. / Mirzoyan, R. et al. | 2011
- S126
-
P.1.019 Neuroprotective properties of a low molecular weight dipeptide analogue of BDNF -GSB-106 in cell cultureLogvinov, I. O. / Antipova, T. A. / Tarasiuk, A. T. / Gudasheva, T. A. et al. | 2011
- S127
-
P.1.021 Different influence of dopaminergic system genes on working memory in healthy subjectsTomaszewska, M. / Borkowska, A. et al. | 2011
- S128
-
P.1.023 Circulatory shock as the physiological basis of delirium tremensGalankin, T. / Galankin, L. N. et al. | 2011
- S129
-
P.1.025 BDNF gene and personality traits in anorexia nervosa patients and healthy subjectsDmitrzak-Weglarz, M. / Skibinska, M. / Szczepankiewicz, A. / Hauser, J. / Slopien, A. / Rybakowski, F. / Rajewski, A. / Maciukiewicz, M. et al. | 2011
- S130
-
P.1.026 Low dose nicotine improves 6-OHDA-induced impairment of memory, oxidative stress and food reward in nucleus accumbensCiobica, A. / Hritcu, L. / Padurariu, M. / Olteanu, Z. / Bild, V. et al. | 2011
- S131
-
P.1.028 Serum levels of somatostatin-28 and its binding sites in medial habenular nucleus differentiate rats responding and non responding to chronic mild stressFaron-Gorecka, A. / Kusmider, M. / Zurawek, D. / Gaska, M. / Gruca, P. / Papp, M. / Dziedzicka-Wasylewska, M. et al. | 2011
- S132
-
P.1.030 The role of environmental effects in the serotonergic and adrenergic mediated neuro-endocrine-behavioural response by Wistar ratsGalfi, M. / Nagyeri, G. / Valkusz, Z. / Radacs, M. / Ocsko, T. / Hausinger, P. / Laszlo, M. / Laszlo, A. / Juhasz, A. / Julesz, J. et al. | 2011
- S134
-
P.1.033 Experimental pharmacokinetics and metabolism of a new potential antipsychoticBoyko, S. S. / Zherdev, V. P. / Ostrovskaya, R. U. / Gudasheva, T. A. / Mesonznic, N. V. / Bastrygin, D. V. / Ivannikova, E. V. et al. | 2011
- S135
-
P.1.035 Antinociceptive, anti-inflammatory and gastroprotective effects of CysLT1 receptor blockers in ratsMarusov, I. / Pchelintsev, M. / Ignatov, Y. et al. | 2011
- S136
-
P.2.001 The presence and clinical implications of comorbid depressive disorder in women with epilepsyTodorova, K. et al. | 2011
- S137
-
P.2.003 Cognitive functioning in depressed patients treated with specific serotonin reuptake inhibitors and tricyclic antidepressantsPanzaru, C. / Tilea, L. et al. | 2011
- S138
-
P.2.004 Psychopharmacological treatment may affect the efficacy of antiviral treatment in patients with chronic hepatitis CDrozdz, W. / Dybowska, D. / Kozielewicz, D. / Halota, W. / Borkowska, A. et al. | 2011
- S139
-
P.2.006 The effects of ZP-122 on prolyl endopeptidase activity in the brain structures of C57BL/6 and Balb/C mice after Porsolt testShipilov, I. A. / Koliasnikova, K. N. / Narkevich, V. B. / Pozdnev, V. F. / Nazarova, G. A. / Zolotov, N. N. et al. | 2011
- S140
-
P.2.008 Treatment of bipolar disorder with somatic comorbidities - an overview of drug-drug interactionsMarinescu, V. / Vrabie, M. et al. | 2011
- S142
-
P.3.002 Clebopride, an antagonist of dopamine type 2 receptors, in low doses improves learning with positive reinforcementMalyshev, A. V. / Zakharov, A. M. / Dubynin, V. A. / Sarkisova, K. Y. et al. | 2011
- S143
-
P.3.004 Family-based association study of glycogen synthase kinase 3 (GSK3)-beta gene polymorphism in schizophreniaSkibinska, M. / Kapelski, P. / Hauser, J. et al. | 2011
- S144
-
P.3.005 Dilept - a novel type of antipsychotic based on neurotensinOstrovskaya, R. U. / Gudasheva, T. A. / Seredenin, S. B. et al. | 2011
- S145
-
P.4.002 Anxiogenic or anxiolytic effects of nociception analogue are dose-dependent and sex-specificIvanova, E. / Sarycheva, N. Y. / Dubynin, V. A. / Kalikhevich, V. N. / Ardemasova, Z. A. / Kamensky, A. A. et al. | 2011
- S146
-
P.4.004 Dipeptide anxiolytic GB-115: new receptor targetsKolik, L. / Gudasheva, T. A. / Seredenin, S. B. et al. | 2011
- S147
-
P.4.006 The bioavailability of afobazol and compound M-11 in ratsBastrygin, D. V. / Viglinskaya, A. O. / Bochkov, P. O. / Emeljanov, M. I. / Novitskaya, Y. G. / Pronina, O. G. / Zherdev, V. P. et al. | 2011
- S149
-
P.4.009 Afobazol as inhibitor of NRH: quinone reductase 2 enzymeKadnikov, I. / Voronin, M. / Seredenin, S. et al. | 2011
- S150
-
P.4.011 Analogues of cyclo-L-prolylglycine and their anxiolytic, nootropic and antihypoxic activityKoliasnikova, K. N. / Nazarova, G. A. / Konstantinopolskiy, M. A. / Gudasheva, T. A. et al. | 2011
- S151
-
P.4.013 Effect of peripheral administration of peptide ligands of opioid receptors on anxiety and locomotor activity in ratsNazarova, G. A. / Koliasnikova, K. N. / Kolpakov, A. A. et al. | 2011
- S152
-
P.4.015 The interlinear effects of the combined injection of afobazol and selective antagonists of serotonin (5-HT) receptors: a behavioural studyNarkevich, V. B. / Shubenina, E. V. / Davydova, A. I. / Kudrin, V. S. / Rayevsky, K. S. et al. | 2011
- S153
-
P.4.017 Antihypoxic and enzyme inhibitory activity of the new anxiolytic drug afobazolKoliasnikova, K. N. / Mozhaeva, T. Y. / Nazarova, G. A. / Zolotov, N. N. et al. | 2011
- S154
-
P.5.002 Natalizumab reduces apathy in relapsing-remitting multiple sclerosis patientsBerkovich, R. et al. | 2011
- S155
-
P.5.004 Neuroprotective effect of proline-containing dipeptide, noopept on PC12 neuronal cellsSalimgareeva, M. K. / Fatkullina, U. S. / Zainullina, L. F. / Vakhitova, J. V. / Ostrovskaya, R. U. / Seredenin, S. B. et al. | 2011
- S157
-
P.5.007 Effect of nanosomic erythropoietin in rats with intracerebral post-traumatic haematoma (hemorrhagic stroke)Solev, I. N. / Elizarova, O. S. / Balabanyan, V. Y. / Litvinova, S. A. / Garibova, T. L. / Voronina, T. A. et al. | 2011
- S158
-
P.5.009 Behavioural and biochemical effects of a novel dipeptide mimetic of nerve growth factor on a model of incomplete global ischemia in ratsPovarnina, P. / Nikolaev, S. V. / Antipova, T. A. / Gudasheva, T. A. et al. | 2011
- S159
-
P.5.011 Unseen face of polypharmacy in Alzheimers disease - a focus on drug-drug interactionsVrabie, M. / Marinescu, V. et al. | 2011
- S160
-
P.6.002 Comparative characteristics of neurocognitive functioning in patients with different types of abuseBushara, N. / Krupitsky, E. / Zvartau, E. / Verbitskaya, E. / Erogova, V. / Tsoy, M. et al. | 2011
- S161
-
P.6.004 Modulation of rewarding effects of psychotropic drugs by GABA and dopamine mechanisms from the bed nucleus of the stria terminalisShabanov, P. / Lebedev, A. / Sheveleva, M. et al. | 2011
- S162
-
P.6.005 Comparative study of the abuse potential of the kappa-opoioid agonist RU-1203Grechko, O. / Eliseeva, N. / Spasov, A. / Anisimova, V. et al. | 2011
- S163
-
P.6.007 Effect of L-glutamine and its dipeptides on the level of voluntary alcohol consumption in ratsPronko, P. S. / Slyahtun, A. H. / Satanovskaya, V. I. / Khomich, T. I. / Gaishmanova, A. V. et al. | 2011
- S164
-
P.6.009 Influence of olfactory bulbectomy on extinction and drug-seeking behaviour in rats exposed to intravenous cocaine self-administrationFilip, M. / Bialko, M. / Wydra, K. / Machowska, K. / Nowak, E. / Suder, A. et al. | 2011
- S165
-
P.6.011 Pharmacological profile of the nicotinic receptor partial agonist cytisine: effects on maintenance and relapse to nicotine seekingRadchenko, E. / Dravolina, O. / Bespalov, A. et al. | 2011
- S167
-
P.6.014 Effect of mitochondrial antioxidant SKQ-1 on the behaviour of albino rats after acute ethanol intoxicationEfimova, E. V. / Kushnir, E. A. / Kalabushev, S. N. / Lovat, M. L. et al. | 2011
- S168
-
P.6.016 Is use of caffeinated energy drinks associated with higher levels of tobacco, alcohol and other drug use in American students?Hull, L. / Dillon, P. M. / OConnell, M. M. / Chitnavis, P. / Svikis, D. S. et al. | 2011
- S169
-
P.7.002 Elevated level of homocysteine in children and adolescents with psychotic and mood disordersKevere, L. / Purvina, S. / Bauze, D. / Zeibarts, M. / Rizevs, A. / Jelisejevs, S. / Caune, M. / Purvins, I. / Andrezina, R. et al. | 2011
- S171
-
P.7.005 BDNF gene polymorphism and Wisconsin Card Sorting Test in children with ADHD and healthy controlsSlopien, A. / Dmitrzak-Weglarz, M. / Borkowska, A. R. / Rybakowski, F. / Witkowska, M. / Hauser, J. / Rajewski, A. et al. | 2011
- S172
-
P.8.002 Hydrolysis of 1-methyl-5-phenyl-3-acetoxy-7-bromo-1,2-dihydro-3H-1,4-benzodiazepine-2-one with the help of pig liver microsomesShesterenko, E. A. / Romanovska, I. I. / Sevastyanov, O. V. / Andronati, S. A. / Pavlovsky, V. I. / Yurpalova, T. I. / Semenishina, E. A. et al. | 2011
- S173
-
P.8.003 Effects of chronic maternal deprivation in white rats and their correction by administration of the ACTH(4-10) analogue semaxSebentsova, E. A. / Volodina, M. A. / Manchenko, D. M. / Andreeva, L. A. / Levitskaya, N. G. / Myasoedov, N. F. et al. | 2011
- S174
-
P.8.005 Alexithymia in oncological patients: the role of hemoglobin, malignancy type and tumor stagingMessina, A. / Fogliani, A. M. et al. | 2011
- S175
-
P.8.007 The biotechnological production of potential neuroprotectants: oligo-3-hydroxybutyratesBonartsev, A. P. / Voinova, V. V. / Mahina, T. K. / Myshkina, V. L. / Bonartseva, G. A. et al. | 2011
- S183
-
PL.03.01 Deep brain stimulation for depression: present and futureMayberg, H. / Holtzheimer, P. / Franco, A. / Kelley, M. / Gross, R. et al. | 2011
- S185
-
S.01.05 Can neuroimaging in schizophrenia predict antipsychotic responseHulshoff Pol, H. E. / Cahn, W. / Kahn, R. S. et al. | 2011
- S187
-
S.03.03 Novel treatment strategies for Alzheimers diseaseGotz, J. / Ittner, L. M. / Matamales, M. et al. | 2011
- S188
-
S.04.02 Antidepressants modulate human hippocampal neurogenesis by activating the glucocorticoid receptorAnacker, C. / Zunszain, P. A. / Cattaneo, A. / Carvalho, L. A. / Thuret, S. / Price, J. / Pariante, C. M. et al. | 2011
- S189
-
S.04.04 The involvement of FK506-binding protein 51 (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stressHartmann, J. / Wagner, K. V. / Hausch, F. / Rein, T. / Schmidt, U. / Touma, C. / Muller, M. B. / Schmidt, M. V. et al. | 2011
- S190
-
S.04.07 Mechanism and behavioural consequences of agonist-induced upregulation of alpha7 nicotinic acetylcholine receptor levels in the rat brainThomsen, M. S. / Christensen, D. Z. / El-Sayed, M. / Hansen, H. H. / Mikkelsen, J. D. et al. | 2011
- S191
-
S.05.01 Clinical characteristics and definitionsCorrell, C. U. et al. | 2011
- S193
-
S.06.03 Disgust sensitivity as a risk factor for contamination-related OCD: evidence from neuroimaging researchMataix-Cols, D. et al. | 2011
- S196
-
S.07.05 Deep brain stimulation of the ventral striatum affects consummatory and motivated behaviour in a location-specific mannervan der Plasse, G. / Schrama, R. / van Seters, S. / Westenberg, H. G. / Vanderschuren, L. J. et al. | 2011
- S197
-
S.07.08 A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypyKoychev, I. / McMullen, K. / Lees, J. / Grayson, L. / Schmechtig, A. / Dawson, G. / Walters, J. / Williams, S. / Deakin, J. F. / Barkus, E. M. et al. | 2011
- S198
-
S.08.03 Ghrelin and drug rewardEngel, J. A. / Landgren, S. / Egecioglu, E. / Dickson, S. L. / Jerlhag, E. et al. | 2011
- S199
-
S.08.05 The ghrelin receptor as drug target for anorexia nervosa?Adan, R. A. / Verhagen, L. A. / Merkestein, M. / Egecioglu, E. / Dickson, S. L. et al. | 2011
- S200
-
S.09.03 From rats to men: deep brain stimulation in rodent models of psychiatric symptomsWinter, C. et al. | 2011
- S201
-
S.10.02 Current major depression and its role in tobacco dependence: state effects on craving, dopamine release, and smoking cessationZawertailo, L. / Busto, U. / Selby, P. et al. | 2011
- S202
-
S.10.04 Is COMT genotype a trait marker for increased sensitivity to cannabis in schizophrenia patients?Kennedy, J. L. / Mackenzie, B. / DeSousa, K. / Tiwari, A. K. / Busto, U. et al. | 2011
- S203
-
S.12.02 Gender differences in drug addiction and relapse: focus on cannabinoidsFattore, L. / Fratta, W. et al. | 2011
- S205
-
S.13.02 Differential diagnosis and treatment of unipolar and bipolar depression in children and adolescentsDiler, R. / Birmaher, B. / Axelson, A. et al. | 2011
- S207
-
S.14.02 Imaging modalities to determine pathophysiological changes in the brain and the blood-brain barrierWardlaw, J. et al. | 2011
- S208
-
S.14.04 Breakdown of the blood-brain barrier in drug abuse and neurodegenerative disorders: nanoparticles as therapeutic option?Sharma, H. S. / Muresanu, D. F. / Sharma, A. / Ali, S. F. et al. | 2011
- S210
-
S.15.05 Genetic epidemiology in addiction researchMunafo, M. et al. | 2011
- S211
-
S.16.03 Hippocampal volume decrease in depression: what can we learn from animal models?Czeh, B. et al. | 2011
- S212
-
S.17.02 Cognitive disturbances in multiple sclerosis patientsDeLuca, J. et al. | 2011
- S214
-
S.18.02 Functional polymorphisms in oxidative and nitrosative stress genesGalecki, P. et al. | 2011
- S216
-
S.19.03 Neonatal immune challenge alters adult prefrontal interneuron maturation during adolescenceODonnell, P. / Calhoon, G. G. / Tseng, K. Y. / Feleder, C. et al. | 2011
- S218
-
S.20.05 Role of 5-HT2B receptor in the neurogenic and behavioural effects induced by antidepressantsDiaz, S. / Doly, S. / Narboux-Neme, N. / Fernandez, S. / Mazot, P. / Maroteaux, L. et al. | 2011
- S220
-
S.22.01 Depression and anxiety in Parkinsons disease: under-diagnosed and undertreatedWittchen, H. / Riedel, O. et al. | 2011
- S222
-
S.23.03 Effects of ecstasy consumption on water homeostasis and secretion of vasopressin and oxytocin: a pharmacogenetic studyWolff, K. / Tsapakis, E. M. / Forsling, M. L. / Aitchison, K. J. et al. | 2011
- S223
-
S.24.01 Removal of perineuronal nets in the amygdala enables selective erasure of fear memoryHerry, C. et al. | 2011
- S225
-
S.25.02 Treating bipolar mania: evidence based evaluation of drug and placebo responsesYildiz, A. / Vieta, E. / Baldessarini, R. J. et al. | 2011
- S228
-
S.27.02 Identification and characterisation of putative ADHD risk genesLesch, K. P. et al. | 2011
- S230
-
S.28.03 Glycine transport inhibitors for the treatment of psychiatric disordersJavitt, D. C. et al. | 2011
- S233
-
E.02.02 Pitfalls, problems and futureSerretti, A. et al. | 2011
- S234
-
E.06.01 Setting the stage - AntidepressantsNutt, D. et al. | 2011
- S237
-
P.1.a.002 Comparative genomic hybridization array study in non-syndromic (primary) autism patientsGumuslu, E. / Cine, N. / Kara, B. / Savli, H. et al. | 2011
- S239
-
P.1.a.005 Aggression /hostility shows a stronger association with the 5-HTTLPR in depressed patients: a possible common pathway for suicidality?Gonda, X. / Fountoulakis, K. N. / Csukly, G. / Bagdy, G. / Pap, D. / Molnar, E. / Laszik, A. / Faludi, G. / Rihmer, Z. et al. | 2011
- S240
-
P.1.a.007 Epistatic interaction of vascular endothelial growth factor (VEGF) and TNF-alpha gene polymorphisms is associated with major depressive disorderLazary, J. / Dome, P. / Halmai, Z. / Kruk, E. / Keszler, G. / Sarosi, A. / Sasvari-Szekely, M. / Faludi, G. et al. | 2011
- S241
-
P.1.a.009 The comparison of gene expression in various brain regions of mice lacking the noradrenaline transporter - TaqMan Low Density Arrays studySolich, J. / Gaska, M. / Kusmider, M. / Faron-Gorecka, A. / Dziedzicka-Wasylewska, M. et al. | 2011
- S243
-
P.1.a.012 Confirmation of association between genetic markers in 5HTR2A and response to mGLU2/3 agonist LY2140023 monohydrate in schizophreniaNisenbaum, L. / Zhao, F. / Downing, A. C. / Munsie, L. M. / Chen, P. / Fijal, B. / Smith, M. R. / Millen, B. A. / Adams, D. H. / Kinon, B. J. et al. | 2011
- S244
-
P.1.a.014 Some predicting ways for people genetically vulnerable to schizophrenia: a family-based studyCheng, C. / Loh, E. W. / Chan, C. H. / Lan, T. H. et al. | 2011
- S245
-
P.1.a.016 Serotonin transporter promoter polymorphism and stressful life events: interactive effects on depressivenessKurrikoff, T. / Hiio, K. / Kiive, E. / Loit, H. M. / Maestu, J. / Veidebaum, T. / Harro, J. et al. | 2011
- S246
-
P.1.a.017 5-HTTLPR carrier status influences cerebral 5-HT4 receptor binding as measured in vivo in humansFisher, P. M. / Holst, K. K. / Haahr, M. T. / Madsen, K. / Jensen, P. S. / Knudsen, G. M. et al. | 2011
- S247
-
P.1.a.019 Neuropharmacological control of genomic networks in the striatumKorostynski, M. / Piechota, M. / Dzbek, J. / Mlynarski, W. / Przewlocki, R. et al. | 2011
- S248
-
P.1.a.021 Glucocorticoid induced FKBP5-gene expression in depressed patients and healthy controlsMenke, A. / Klengel, T. / Eichelkraut, A. / Preis, L. / Rex-Haffner, M. / Uhr, M. / Holsboer, F. / Binder, E. B. et al. | 2011
- S250
-
P.1.b.002 Protective effect of agmatine in subarachnoid haemorrhage model in ratsYazir, Y. / Ersahin, M. / Alyuruk, B. / Toklu, H. Z. / Gumru, S. / Ceylan, S. / Aricioglu, F. et al. | 2011
- S251
-
P.1.b.004 Mismatch negativity in depressed patients under selective noradrenergic and serotonergic antidepressantsNorra, C. / Peddersen, A. / Juckel, G. / Waniek, S. et al. | 2011
- S253
-
P.1.c.001 Mechanisms of antidepressant activity for TC-5214: a selective, centrally-acting neuronal nicotinic channel modulatorQuirk, M. / Johnson, E. / Moore, W. C. / Doherty, J. / Bertrand, D. et al. | 2011
- S254
-
P.1.c.003 Effects of levetiracetam on cognitive functions in miceCelikyurt, I. K. / Ulak, G. / Akar, F. Y. / Mutlu, O. / Mulayim, S. / Erden, F. et al. | 2011
- S255
-
P.1.c.005 Protective effect of Platycodon grandiflorum in a middle cerebral artery occlusion and reperfusion model of cerebral ischemia in ratsKim, E. / Lee, M. / Lee, H. A. et al. | 2011
- S256
-
P.1.c.007 Depressive -like behavioural alterations induced by intranigral MPTP, 6-ODHA, LPS and rotenone models of Parkinsons diseaseSantiago, R. / Barbiero, J. / Lima, M. / Andreatini, R. / Vital, M. et al. | 2011
- S258
-
P.1.c.010 Cytochrome P450 mediates the synthesis of monoaminergic neurotransmitters in the brainDaniel, W. A. / Bromek, E. / Haduch, A. / Wojcikowski, J. / Golembiowska, K. et al. | 2011
- S259
-
P.1.c.012 Is the Nugent Test a useful biomarker for the escitalopram dosage?Marin, R. / Lozano, R. / Pascual, A. / Santacruz, M. J. / Sebastian, F. / Vazquez, M. D. / Lozano, A. et al. | 2011
- S261
-
P.1.c.015 The role of estrogen and testosterone in female rats in behavioural models of relevance to schizophreniaGogos, A. / Kwek, P. / van den Buuse, M. et al. | 2011
- S262
-
P.1.c.017 Duloxetine prevents 3,4-methylenedioxymethamphetamine induced serotonin release in vitro and psychostimulant effects in humansSimmler, L. D. / Hysek, C. M. / Huwyler, J. / Liechti, M. E. et al. | 2011
- S263
-
P.1.c.019 The effect of lithium on oxidant-antioxidant balance in vitro and in neuronal cell culturesGawlik, O. / Rabe-Jablonska, J. et al. | 2011
- S264
-
P.1.c.020 Memantine elicits action potential bursts in the central snail neuronHsu, H. Y. / Chen, Y. H. et al. | 2011
- S265
-
P.1.c.022 Effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) on prosocial feelings and oxytocin plasma levels in humansHysek, C. M. / Simmler, L. D. / Nicola, V. G. / Liechti, M. E. et al. | 2011
- S266
-
P.1.c.024 The effect of the brain noradrenergic system on liver cytochrome P450: the role of neuroendocrine regulationHaduch, A. / Sadakierska-Chudy, A. / Golembiowska, K. / Daniel, W. A. et al. | 2011
- S268
-
P.1.c.027 Neurorestorative properties of mildronate in the rat model of Parkinsons diseaseBeitnere, U. / Isajevs, S. / Svirina, D. / Sausa, S. / Rostoka, E. / Klusa, V. et al. | 2011
- S269
-
P.1.c.029 Behavioural effect of pinealectomy in rat models of Parkinsons disease induced by MPTP and 6-ODHACapitelli, C. / da Silva, V. D. / Vital, M. et al. | 2011
- S270
-
P.1.c.031 Effects of citalopram treatment on the lipopolysaccharide (LPS) induced alterations in contextual learning and brain plasticity in adult mouse hippocampusJaako, K. / Shastin, D. / Zharkovsky, A. et al. | 2011
- S272
-
P.1.c.034 Cataleptic effect of lipopolysaccharide in mice: modulation by serotonergic agentsBazovkina, D. / Kulikov, A. et al. | 2011
- S273
-
P.1.c.036 Lipopolysaccharide -induced oxidative stress in rat striatumGolembiowska, K. / Kaminska, K. / Gawlik, M. / Noworyta-Sokolowska, K. et al. | 2011
- S274
-
P.1.c.038 Anticonvulsant effect of hydroalcoholic extract of Zizyphus jujuba: pharmacodynamic and pharmacokinetic interaction with phenytoinReeta, K. H. / Pahuja, M. / Gupta, Y. K. et al. | 2011
- S275
-
P.1.c.040 Partial occupancy of the glycine transporter type 1 by RG1678 leads to efficacy in animal models relevant to schizophreniaAlberati, D. / Borroni, E. / Moreau, J. L. / Wong, D. / Wallace, T. / Hainzl, D. / Pinard, E. / Wettstein, J. G. et al. | 2011
- S276
-
P.1.c.041 The effects of 5-HT1B receptor modulation on glutamatergic neurotransmission in vivoAlvarsson, A. / Eriksson, T. M. / Stan, T. / Hascup, K. N. / Hascup, E. R. / Gerhardt, G. A. / Svenningsson, P. et al. | 2011
- S277
-
P.1.c.043 Effects of esmirtazapine on driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotypeConen, S. / Theunissen, E. L. / Ramaekers, J. G. et al. | 2011
- S279
-
P.1.c.046 A modulatory effect of the nitric oxide donor molsidomine on the brain dopamine in 6-ODHA-lesioned rats treated chronically with L-DOPALenda, T. / Czarnecka, A. / Zapala, M. / Konieczny, J. / Lorenc-Koci, E. et al. | 2011
- S280
-
P.1.c.048 Alpha 1 antagonist in dorsal raphe mediates analgesia induced by defence behaviour evoked by stimulation of the dorsomedial hypothalamusSalgado, C. J. / Freitas, R. L. / Coimbra, N. C. et al. | 2011
- S281
-
P.1.c.050 Autologous bone marrow mononuclear cell therapy in MPTP-lesioned ratsCapitelli, C. S. / Salomao, C. L. / da Silva, V. D. / Vital, M. et al. | 2011
- S282
-
P.1.c.052 Condition of thiol-disulfide and nitric oxide balance in brain tissues of rats with alloxan diabetes treated with neuroprotective drugsLievykh, A. E. / Zhylyuk, V. I. / Mamchur, V. I. et al. | 2011
- S283
-
P.1.c.053 Influence of neuroprotective drugs on endothelial dysfunction and platelet aggregation in conditions of alloxan diabetes of ratsBespala, D. V. / Lievykh, A. E. / Zhylyuk, V. I. / Mamchur, V. I. et al. | 2011
- S284
-
P.1.c.055 Metadoxine:a novel 5HT-2B receptor antagonist with a possible therapeutic role in treating ADHDDaniely, Y. / Reich, D. / Megiddo, D. / Manor, I. et al. | 2011
- S285
-
P.1.c.057 Characterisation of behavioural, neurochemical and histological alterations promoted by bilateral intranigral rotenone administrationMoreira, C. G. / Ariza, D. / Dombrowski, P. A. / Sabioni, P. / Bortolanza, M. / Da Cunha, C. / Lima, M. M. / Barbiero, J. K. / Vital, M. A. et al. | 2011
- S286
-
P.1.c.058 The involvement of adenosine A1 receptors in the antihyperalgesic effect of levetiracetamStepanovic-Petrovic, R. / Micov, A. / Tomic, M. et al. | 2011
- S287
-
P.1.c.060 (+-)3,4-Methylenedioxyamphetamine inhibits a TEA-sensitive potassium current in the hippocampusWu, Y. T. / Chen, Y. H. / Lin, C. H. et al. | 2011
- S288
-
P.1.c.062 Importance of targeting mitochondria in the search for new neuroprotectorsShevtsova, E. / Vinogradova, D. / Kireeva, E. / Bachurin, S. et al. | 2011
- S290
-
P.1.d.001 The effects of lesions of the raphe nuclei on phencyclidine-induced c-fos expression in the rat brain: implications for schizophreniaKusljic, S. / Van den Buuse, M. et al. | 2011
- S291
-
P.1.d.003 Effects of zaprinast and rolipram on spatial memory in the radial arm maze test in miceUlak, G. / Komsuoglu, I. C. / Mutlu, O. / Akar, F. Y. / Erden, F. et al. | 2011
- S292
-
P.1.d.005 Depressive -like behaviour of Wistar rats exposed to chronic unpredictable stress: effect of long-term caffeine administrationTchekalarova, J. / Pechlivanova, D. / Atanasova, T. / Yakimova, K. / Nikolov, R. et al. | 2011
- S294
-
P.1.d.008 Blockade of D2 receptor with low dose of 17b-estradiol corrects depression-like behaviour in female ratsFedotova, J. / Frolova, G. et al. | 2011
- S295
-
P.1.d.010 Resveratrol prevents memory deficits caused by chronic unexpected mild stress in ratsUtkan, T. / Ozer, C. / Gocmez, S. / Gacar, N. / Aricioglu, F. et al. | 2011
- S296
-
P.1.d.012 The anxiogenic potential of ciprofloxacin in rats: the assessment of changes in open-field and elevated plus-maze behaviourMilitaru, F. / Buzoianu, A. D. / Militaru, V. et al. | 2011
- S297
-
P.1.d.013 Chronic unpredictable stress-induced antinociception: effect of long-term caffeine treatmentPechlivanova, D. / Tchekalarova, J. / Petkova, Z. / Nikolov, R. / Yakimova, K. et al. | 2011
- S298
-
P.1.d.015 Disturbing effects of spatial memory by the soluble guanylate cyclase inhibitor ODQ and the nNOS inhibitor 7-NI in the modified elevated plus maze testMutlu, O. / Akar, F. Y. / Komsuoglu, I. C. / Ulak, G. / Erden, F. et al. | 2011
- S299
-
P.1.d.017 Role of elevated plus-maze learning in the absence of one trial tolerance in spontaneously hypertensive ratsLopez, G. B. / Takatsu-Coleman, A. L. / Calzavara, M. B. / Silva, R. H. / Abilio, V. C. / Frussa-Filho, R. et al. | 2011
- S300
-
P.1.d.019 Selective ablation of mGluR5 receptors on dopamine D1-expressing neurons abolishes novelty-seeking behavioursSikora, M. / Solecki, W. / Engblom, D. / Parkitna, J. R. et al. | 2011
- S301
-
P.1.d.021 Ethanol reduces the tolerance to delay of reinforcement and induces impulsivity in ratsSaghazadeh, M. / Rezazadeh, P. / Yazdanpanah, H. / Mesdaghinia, A. et al. | 2011
- S302
-
P.1.d.023 Altered brain derived neurotrophic factor signaling and serotonergic neurotransmission in NCAM-deficient miceAonurm-Helm, A. / Zharkovsky, A. et al. | 2011
- S303
-
P.1.e.001 Neural substrates of fear conditioning and extinction recall in a delayed extinction taskLueken, U. / Maslowski, N. I. / Wittmann, A. / Pilhatsch, M. / Wittchen, H. U. et al. | 2011
- S304
-
P.1.e.003 Neuropsychological correlates of brain metabolite measures in chronic schizophreniaSzulc, A. / Galinska, B. / Tarasow, E. / Kubas, B. / Konarzewska, B. / Waszkiewicz, N. et al. | 2011
- S306
-
P.1.e.006 Involvement of the endocannabinoid system in executive function: a pharmacological fMRI study with delta9-tetrahydrocannabinol (THC)Bossong, M. G. / Jansma, J. M. / van Hell, H. H. / Jager, G. / Kahn, R. S. / Ramsey, N. F. et al. | 2011
- S307
-
P.1.e.008 High -resolution regional cerebral blood volume mapping by using pharmacological high-field magnetic resonance imagingCleppien, D. / Sartorius, A. / Gass, N. / Noori, H. / Zheng, L. / Weber-Fahr, W. et al. | 2011
- S309
-
P.1.e.011 Default -mode network deficits in medication naive ADHD childrenChoi, J. / Jeong, B. et al. | 2011
- S310
-
P.1.e.013 Effectiveness of cerebral hemoglobin data in educational research of developmental disorderOkamoto, N. / Kuroda, Y. et al. | 2011
- S311
-
P.1.e.015 Brainstem raphe alteration in depressed and suicidal patients recorded on transcranial sonographyStrineka, M. / Budisic, M. / Karlovic, D. / Bene, R. / Lovrencic-Huzjan, A. / Buljan, D. / Demarin, V. et al. | 2011
- S313
-
P.1.e.018 How adolescent brains are activated to feedback taskChoi, W. / Son, J. et al. | 2011
- S314
-
P.1.e.020 Caudate grey matter volume in obsessivecompulsive disorder is influenced by adverse childhood experiences and ongoing drug treatmentPoletti, S. / Radaelli, D. / Pozzi, E. / Smeraldi, E. / Benedetti, F. et al. | 2011
- S315
-
P.1.e.022 Effect of electroconvulsive therapy on serotonin-1A receptor binding in major depressive disorderBaldinger, P. / Lanzenberger, R. / Hahn, A. / Mitterhauser, M. / Wadsak, W. / Micskei, Z. / Ungersbock, J. / Winkler, D. / Kasper, S. / Frey, R. et al. | 2011
- S316
-
P.1.e.023 Influence of the 5-HTTLPR polymorphism on brain structure in treatment-resistant major depressive disorderPhillips, J. L. / Batten, L. A. / Aldosary, F. / Tremblay, P. / Du, L. / Blier, P. et al. | 2011
- S317
-
P.1.e.025 Quantitative EEG in animal models of psychosis: the impact of behaviourPalenicek, T. / Fujakova, M. / Tyls, F. / Brunovsky, M. / Kubesova, A. / Horacek, J. / Krajca, V. et al. | 2011
- S318
-
P.1.e.027 Serotonin -1A receptor binding in the dorsal raphe nucleus is associated with hippocampal grey matter volumeKraus, C. / Hahn, A. / Savli, M. / Hoflich, A. / Baldinger, P. / Kranz, G. S. / Mitterhauser, M. / Wadsak, W. / Kasper, S. / Lanzenberger, R. et al. | 2011
- S319
-
P.1.e.028 Resting -state functional connectivity of the raphe nucleiHoeflich, A. / Hahn, A. / Kraus, C. / Baldinger, P. / Kranz, G. S. / Losak, J. / Windischberger, C. / Kasper, S. / Lanzenberger, R. et al. | 2011
- S320
-
P.1.e.030 In vivo monoamine transporter occupancy by venlafaxine and milnacipran in non-human primatesTakano, A. / Nag, S. / Halldin, C. / Farde, L. et al. | 2011
- S321
-
P.1.e.032 Test/Retest reliability of an imaging task battery for pharmaco-fMRIPlichta, M. / Schwartz, A. J. / Wilson, F. J. / Colman, P. J. / Grimm, O. / Tost, H. / Haddad, L. / Sauer, C. / Kirsch, P. / Meyer-Lindenberg, A. et al. | 2011
- S322
-
P.1.e.033 White matter diffusivity changes in obsessive-compulsive disorder: a diffusion tensor MRI study with Tract-Based Spatial StatisticsGiacosa, C. / Ruffini, C. / Radaelli, D. / Poletti, S. / Benedetti, F. et al. | 2011
- S323
-
P.1.e.035 Combined voxel-based morphometry and region of interest methods for studying the hippocampus in Asperger syndrome: preliminary findingsParellada, M. / Janssen, J. / Reig, S. / Pina, L. / Navas-Sanchez, F. J. / Desco, M. / Arango, C. et al. | 2011
- S325
-
P.1.e.038 Differences in corpus callosum composition between Asperger syndrome and healthy adolescents: a tractography studyNavas-Sanchez, F. J. / Merchan-Naranjo, J. / Reig, S. / Janssen, J. / Arango, C. / Parellada, M. / Desco, M. et al. | 2011
- S326
-
P.1.f.002 The effects of early post-natal treatment with ketamine on learning, memory and nociception in ratsDoncheva, N. / Getova, D. et al. | 2011
- S327
-
P.1.f.004 Behavioural and neurodevelopmental effects of ACTH and glucocorticoids in neonatal ratsDygalo, N. / Kalinina, T. S. / Shemenkova, T. V. / Vechkapova, S. O. / Manshanov, P. N. / Bulygina, V. V. et al. | 2011
- S328
-
P.1.f.005 The cortisol awakening response during adolescencePlatje, E. / Vermeiren, R. R. / Doreleijers, T. H. / Meeus, W. / Koot, H. M. / van Lier, P. A. / Frijns, T. / Jansen, L. M. et al. | 2011
- S329
-
P.1.g.002 Neuropsychological dysfunctioning in schizophrenia: a hospital based studyMishra, B. P. / Chaudhry, R. K. et al. | 2011
- S330
-
P.1.g.004 Relationship between absorption and personality using the revised NEO personality inventory in undergraduate studentsLee, J. S. / Yoon, S. M. / Lee, S. B. et al. | 2011
- S332
-
P.1.g.007 How does a trivial head injury result in enduring symptoms? A prospective investigation of outcome after mild traumatic brain injuryHou, R. / Moss-Morris, R. / Peveler, R. / Belli, A. / McVeigh, S. / Bradley, B. / Mogg, K. et al. | 2011
- S333
-
P.1.g.009 Cognitive functioning in patients with schizophrenia vs bipolar disorder: an observational studyCerveri, G. / Venturi, V. / Volonteri, L. S. / Mauri, M. C. / Mazzocchi, A. / Mencacci, C. et al. | 2011
- S334
-
P.1.g.011 Comparative study of the effects of tacrine and rivastigmine on passive avoidance tests in ratsDimitrova, D. / Getova, D. et al. | 2011
- S335
-
P.1.g.012 The pro-cognitive profile of the phosphodiesterase 2A inhibitor BCR909 highlights its utility as a novel treatment for diseases with cognitive declineLangen, B. / Dost, R. / Egerland, U. / Hage, T. / Lankau, H. J. / Hoefgen, N. et al. | 2011
- S336
-
P.1.g.014 Cognition and functioning of patients with first psychotic episode and relation with BDNFGarcia-Lecumberri, B. / Gonzalez-Ortega, I. / de Azua, S. R. / Ugarte, A. / Martinez-Cengotitabengoa, M. / Alberich, S. / Saenz, M. / Gutierrez, M. / Zorrilla, I. / Gonzalez-Pinto, A. et al. | 2011
- S337
-
P.1.g.016 Development of daily self care activities to improve social functioning of people with mild mental retardation attending day care centersRenemane, L. / Purina, I. / Kupca, B. et al. | 2011
- S339
-
P.1.g.019 Reliability and validity of an Arabic Moroccan colloquial language version of the Temperament and Character InventoryEl Mahfoudi, I. / Dervaux, A. / Agoub, M. / Pelissolo, A. / Laqueille, X. / Moussaoui, D. / Kadri, N. et al. | 2011
- S340
-
P.1.g.021 The effect of thyroid hormone levels on short-term memory and plasticity in dentate gyrusArtis, A. S. / Suer, C. / Dolu, N. / Alel, G. et al. | 2011
- S341
-
P.1.g.023 Paired pulse facilitation as an indicator of short term memory in cold exposed ratsDolu, N. / Suer, C. / Artis, A. S. / Kavraal, S. et al. | 2011
- S342
-
P.1.g.025 Effects of central administration of the indirect cannabinoid agonist URB597 in the modulation of emotional memory in ratsRatano, P. / Trezza, V. / Morena, M. / Manduca, A. / Miele, J. / Campolongo, P. / Cuomo, V. et al. | 2011
- S343
-
P.1.g.026 Relationships between affective symptoms, psychomotor performance, vigilance impairment and sleep quality in pure chronic fatigueNeu, D. / Montana, X. / Gilson, M. / Sentissi, O. / Mairesse, O. / Peigneux, P. / Linkowski, P. / Le Bon, O. / Verbanck, P. et al. | 2011
- S344
-
P.1.g.028 Cognitive effects and Fluoro Jade-C staining in the assessment of 2-vessel occlusion model of brain ischemia in miceSchiavon, A. P. / Soares, L. M. / Ferreira, R. R. / Gomes, L. A. / Milani, H. / de Oliveira, R. M. et al. | 2011
- S345
-
P.1.g.030 Neuropsychological changes in children with nocturnal enuresisEssawy, H. / El Said, N. / Shaker, H. / El Fattah, D. A. / Ezzat, M. et al. | 2011
- S347
-
P.1.g.033 Possible correction of neurocognitive deficits in schizophrenia patients with fluvoxamineSofronov, A. / Savelyev, A. / Spikina, A. et al. | 2011
- S348
-
P.1.h.001 Discordance between estimations of prevalence of ADHD disorder in Europe: an indicator of an unmet need for treatmentHormaechea-Beldarrain, J. A. / Prieto, L. et al. | 2011
- S350
-
P.1.h.004 The cost effectiveness of a modified assertive community treatment programme in KoreaYu, J. / Lee, K. / Kim, S. / Ki, S. / Lee, Y. et al. | 2011
- S351
-
P.1.h.006 Study quality and placebo response in randomised controlled trials in schizophrenia conducted 1966-2009Agid, O. / Siu, C. / Potkin, S. / McDonald, K. / Benattia, I. / Remington, G. et al. | 2011
- S352
-
P.1.i.001 Serum leptin level and its association with fatigue in patients with chronic hepatitis C virus infectionel Meguid, M. A. / El Gindy, E. M. / El Din, F. A. / Mostafa, M. M. et al. | 2011
- S353
-
P.1.i.003 Depression, anxiety and delirium are associated with thyroid axis function in brain tumor patientsBunevicius, A. / Deltuva, V. P. / Tamasauskas, S. / Tamasauskas, A. / Bunevicius, R. et al. | 2011
- S354
-
P.2.a.002 Cognitive functions among women and men suffering from depressive disordersTalarowska, M. / Florkowski, A. / Galecki, P. et al. | 2011
- S356
-
P.2.a.005 Dosing of aripiprazole adjunctive therapy for Asian patients with major depressive disorder: a 24-week open label trialBai, Y. M. et al. | 2011
- S357
-
P.2.a.007 Quantifying rater drift on the HAM-D: implications for reliability, sample size, and ongoing training strategyDeFries, A. / Rothman, B. / Yavorsky, C. / Opler, M. / Gordon, J. / Tourian, K. / Pitrosky, B. / Vialet, C. et al. | 2011
- S358
-
P.2.a.008 Why do patients not tell the truth to their physician? A large-scale internet surveySawada, N. / Uchida, H. / Watanabe, K. / Kikuchi, T. / Nio, S. / Kitahata, R. / Yoshida, K. / Kashima, H. / Mimura, M. et al. | 2011
- S359
-
P.2.a.010 Treatment of postpartum depression with psychotherapy and add-on sertraline: a double-blind, randomised, placebo-controlled studyBloch, M. / Meiboom, H. / Lorberblat, M. / Aharonov, I. / Bluvshtein, I. / Ben-Itzhak, S. / Schreiber, S. et al. | 2011
- S360
-
P.2.a.012 Cordance as a biomarker in sleep-EEG for depression: responders versus nonresponders: a naturalistic study after antidepressant medicationPawlowski, M. / Dresler, M. / Holsboer, F. / Steiger, A. et al. | 2011
- S361
-
P.2.a.014 Early partial improvement in combination with genetic variants as a predictor in major depressive disorder treatment: the result of two RCTsKato, M. / Wakeno, M. / Tetsuo, S. / Nonen, S. / Takekita, Y. / Azuma, A. / Kinoshita, T. et al. | 2011
- S362
-
P.2.a.016 Extended release quetiapine efficacy in elderly patients with major depressive disorder by anxiety, sleep disturbance and pain levelsMontgomery, S. / Altamura, A. C. / Katila, H. / Datto, C. / Szamosi, J. / Eriksson, H. et al. | 2011
- S363
-
P.2.a.017 Depressed mood and lack of interest differentially predict remission after adjunctive aripiprazole treatment in studies of MDDGismondi, R. / Friedman, E. S. / Wisniewski, S. R. / Ammerman, D. / Marler, S. V. / Forbes, R. A. / Loze, J. Y. / Baker, R. et al. | 2011
- S364
-
P.2.a.019 Impact of insomnia on treatment of depression in adolescentsEmslie, G. / Kennard, B. / Mayes, T. et al. | 2011
- S365
-
P.2.a.020 The effects of escitalopram on sleep problems in patients with major depressive disorder or GAD: a comparison with SSRIs and SNRIsStein, D. / Lopez, A. G. et al. | 2011
- S366
-
P.2.a.022 Phase 3 dose selection for PNB01, a novel fixed dose combination antidepressant inducing a faster and sustained responseBuntinx, E. / Bol, K. / van den Berg, P. / Haazen, L. / de Chaffoy, D. et al. | 2011
- S367
-
P.2.a.024 Effectiveness of mindfulness-based therapies as an alternative or adjuvant of antidepressants in the treatment of depressionBertolin-Guillen, J. M. / Bertolin-Colilla, M. et al. | 2011
- S368
-
P.2.b.002 Adverse effects of antipsychotic and mood stabilising treatment in bipolar disorders: relation with cognitive dysfunctionsKalwa, A. / Pirog-Balcerzak, A. / Luks, M. / Jablonska, A. / Rzewuska, M. et al. | 2011
- S370
-
P.2.b.005 Blockade of glutamate NMDA receptors in the rat ventromedial prefrontal cortex induces antidepressant-like effectsPereira, V. S. / Joca, S. R. et al. | 2011
- S371
-
P.2.b.007 Serotonin participation in the antidepressantlike effect induced by hippocampal nNOS inhibitionSato, V. A. / Sales, A. J. / Joca, S. R. et al. | 2011
- S372
-
P.2.b.009 The melanin-concentrating hormone system and emotional-like behaviourGarcia-Fuster, M. J. / Parks, G. S. / Clinton, S. M. / Watson, S. J. / Akil, H. / Civelli, O. et al. | 2011
- S374
-
P.2.b.012 Trace amine-associated receptor mRNA expression in the mouse brainLundius, E. G. / Svenningsson, P. et al. | 2011
- S375
-
P.2.b.014 Modulation of 5-HT2A and 5-HT2C receptor expression levels by fluoxetine in a genetic mice model of depressionBjork, K. / Zhang, X. / El Yacoubi, M. / Vaugeois, J. / Svenningsson, P. et al. | 2011
- S376
-
P.2.b.016 Preclinical characterisation of the novel antidepressant Lu AA21004: key role for the 5-HT3 receptors blockadeHaddjeri, N. / Etievant, A. / Ebert, B. / Sanchez, C. / Betry, C. et al. | 2011
- S377
-
P.2.b.018 Progesterone withdrawal models of depression in rats: behavioural characterisation and efficacy of Lu AA21004 and fluoxetineGulinello, M. / Li, Y. / Pehrson, A. / Sanchez, C. et al. | 2011
- S379
-
P.2.b.021 Functional connectivity between cingulate cortex, anteroventral thalamus and hippocampus in rats vulnerable to depressionKanarik, M. / Matrov, D. / Koiv, K. / Tordera, R. / Del Rio, J. / Harro, J. et al. | 2011
- S380
-
P.2.b.023 Role of alpha2-adrenoceptor in trazodone modulatory effect of 5-HT cortical levelsGarrone, B. / De Santi, S. / DAmico, D. / Mancini, F. / Mangano, G. / Magnani, M. / Polenzani, L. / Guglielmotti, A. et al. | 2011
- S381
-
P.2.b.024 The influence of treatment-resistance on the serotonin 2A receptor in unipolar melancholic depressionBaeken, C. / De Raedt, R. / Bossuyt, A. et al. | 2011
- S382
-
P.2.b.026 Psychosocial stress affects core body temperature in tree shrews: a new statistical modelBianchi, M. / Bate, S. / Bauerle, R. / Baulieu, E. E. / Fuchs, E. et al. | 2011
- S383
-
P.2.c.002 Agomelatine versus selective serotoninergic reuptake inhibitors in major depressive disorder and comorbid diabetes mellitusVasile, D. / Vasiliu, O. / Vasile, M. L. / Terpan, M. / Ojog, D. G. et al. | 2011
- S384
-
P.2.c.003 A placebo-controlled study of EB-1010, a novel triple re-uptake inhibitor, in patients with major depressive disorderTran, P. / Bradshaw, M. / McKinney, A. / Bymaster, F. / Skolnick, P. / Czobor, P. / Huang, N. / Manthis, J. / Fava, M. et al. | 2011
- S385
-
P.2.c.005 The effect of repetitive transcranial magnetic stimulation (rTMS) in major depressive disorder with partial remission: an eight months follow-up studyCharnsil, C. / Suttajit, S. / Boonyanaruthee, V. / Leelarphat, S. et al. | 2011
- S386
-
P.2.c.007 Bupropion for interferon-alpha-induced depression in patients with hepatitis C viral infection: an open-label studySu, K. / Chen, W. / Lai, H. / Peng, C. / Huang, C. / Pariante, C. et al. | 2011
- S388
-
P.2.c.010 The change of platelet counts after administrations of escitalopram, venlafaxine, bupropion in depressive patientsBahk, W. / Wang, H. R. / Woo, Y. S. / Min, K. J. / Shin, Y. C. / Lee, S. Y. / Song, H. R. et al. | 2011
- S389
-
P.2.c.012 Adjunctive tianeptine for partial or nonresponders to selective serotonin reuptake inhibitor treatment in major depressive disorderBahk, W. M. / Woo, Y. S. / Jeong, J. H. / Kim, W. / Sung, H. M. / Koo, B. H. / Lee, S. H. / Jon, D. I. / Min, K. J. / Yoon, B. H. et al. | 2011
- S390
-
P.2.c.014 Rates and risk factors to readmission before one year after discharge in unipolar depressive patientsColomer, M. G. / Rodriguez, E. N. / Guitart, A. P. / Lopez, M. M. / Casadevall, J. R. / Dalmau, P. B. et al. | 2011
- S391
-
P.2.c.015 Symptoms concerning sleep difficulties and daytime function in depressive patients: the role of escitalopramSaltos, L. / Papalexi, E. / Fokas, K. / Christoforidis, C. / Stathakis, I. / Gallios, D. / Giailoglou, D. / Parashos, I. A. et al. | 2011
- S392
-
P.2.c.017 Creating a new clinically relevant endpoint in the PNB01 trial programme: the Early and Sustained Antidepressant Response (ESR)Haazen, L. / Buntinx, E. / Van den Broeck, R. / de Chaffoy, D. / Thase, M. E. et al. | 2011
- S393
-
P.2.c.019 Galactorrhea induced by clomipramine: a case reportErtekin, B. A. / Tufan, A. E. / Bilici, R. / Ertekin, E. et al. | 2011
- S394
-
P.2.c.020 Synthesising evidence in clinical psychopharmacology and beyond: a re-examination of published meta-analysesHuf, W. / Kalcher, K. / Pail, G. / Boubela, R. / Pezawas, L. / Windischberger, C. / Moser, E. / Friedrich, M. E. / Filzmoser, P. / Kasper, S. et al. | 2011
- S395
-
P.2.c.022 Metabolic syndrome in women with depressive disorder versus schizophreniaMarinescu, D. / Marinescu, I. / Pirlog, M. C. et al. | 2011
- S396
-
P.2.c.024 A double-blind, randomised, placebocontrolled, relapse-prevention study with Lu AA21004 in patients with major depressive disorderDragheim, M. / Loft, H. / Florea, I. / Boulenger, J. P. et al. | 2011
- S397
-
P.2.c.026 Rapid versus slow titration of paroxetine antidepressant treatment in elderly population: an observational studyGibiino, S. / Fabbri, C. / Serretti, A. et al. | 2011
- S398
-
P.2.c.028 An independent meta-analysis on the efficacy of agomelatine versus placebo and versus SSRIs in major depressionBallesteros, J. / Tarapues, M. / Rueda, J. R. / Santos, B. et al. | 2011
- S399
-
P.2.c.029 Effectiveness of agomelatine in usual clinical practice in major depressive disorders (MDD) outpatientsLupo, C. / Corral, R. / Galeno, R. / Marquez, M. et al. | 2011
- S400
-
P.2.c.031 An Italian study on depressive disease (STIMA-D): characteristics and perceptions of Italian psychiatristsAguglia, E. A. / Altamura, C. A. / Biggio, G. B. / Guazzelli, M. G. / Mencacci, C. M. et al. | 2011
- S401
-
P.2.d.001 1,2,3,4-Tetrahydroisoquinoline produces antidepressant-like effects in modified rat forced swimming test: comparison with imipramineWasik, A. / Michaluk, J. / Mozdzen, E. / Romanska, I. / Antkiewicz-Michaluk, L. et al. | 2011
- S403
-
P.2.d.004 Participation of the NMDA-NO-sGC pathway of the ventral hippocampus in the modulation of depressive-like behaviour in ratsDiniz, C. / Joca, S. / Casarotto, P. et al. | 2011
- S404
-
P.2.d.006 The novel antidepressant Lu AA21004 exerts its multi-modal activity through serotonergic targetsSanchez, C. / Nielsen, S. M. / Pehrson, A. / Zhong, H. / Lassen, A. B. / Bisulco, S. / Mork, A. / Wegener, G. / Stensbol, T. B. et al. | 2011
- S405
-
P.2.d.008 Antidepressant -like action of medial prefrontal cortex deep brain stimulation is modulated by glial systemEtievant, A. / Oosterhof, C. A. / Betry, C. / Abrial, E. / Lambas-Senas, L. / Scarna, H. / Lucas, G. / Haddjeri, N. et al. | 2011
- S406
-
P.2.d.009 Repeated treatment with antidepressants and risperidone changed the reactivity of the central serotonin system in miceRogoz, Z. / Kabzinski, M. et al. | 2011
- S407
-
P.2.d.011 Lu AA21004, a novel antidepressant, modulates neurotransmitter levels and theta oscillations, and exerts pro-cognitive effects in ratsMork, A. / Montezinho, L. C. / Hovelso, N. / Karlsson, J. J. / Murphy, C. T. / Plath, N. / Bang-Andersen, B. / Sanchez, C. / Stensbol, T. B. et al. | 2011
- S408
-
P.2.d.013 Cannabinoid CB1 receptor expression and G protein coupling in a genetic model of depressionSousa, V. C. / Zhang, X. / Qi, H. / El Yacoubi, M. / Vaugeois, J. M. / Svenningsson, P. et al. | 2011
- S410
-
P.2.d.016 Neuropathic pain prevention by serotonin 5-HT2B receptor: role in early immune responseUrtikova, N. / Van Steenwinckel, J. / Doly, S. / Maroteaux, L. / Pohl, M. / Conrath, M. et al. | 2011
- S411
-
P.2.d.018 Agomelatine differentially modulates neuronal plasticity markers and MAP-2 in the rat PFC, hippocampus and amygdalaLadurelle, N. / Gabriel, C. / Mocaer, E. / Baulieu, E. E. / Bianchi, M. et al. | 2011
- S413
-
P.2.d.021 Antidepressant -like effect of creatine in mice: involvement of the dopaminergic systemCunha, M. / Machado, D. G. / Capra, J. C. / Jacinto, J. / Bettio, L. E. / Rodrigues, A. L. et al. | 2011
- S414
-
P.2.d.023 Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stressMocaer, E. / Dagyte, G. / Crescente, I. / Postema, F. / Seguin, L. / Gabriel, C. / Den Boer, J. A. / Koolhaas, J. M. et al. | 2011
- S415
-
P.2.d.025 Effects of synthetic inhibitor of prolyl endopeptidase benzyloxycarbonyl-methionyl-2(S)-cyanopyrrolidine in Porsolt forced swim testKrupina, N. A. / Bogdanova, N. G. / Khlebnikova, N. N. / Zolotov, N. N. / Orlova, I. N. et al. | 2011
- S416
-
P.2.d.026 Chronic administration of quetiapine increases norepinephrine and serotonin neurotransmission in the rat brainChernoloz, O. / El Mansari, M. / Blier, P. et al. | 2011
- S417
-
P.2.e.001 Methylene blue for residual symptoms and for cognitive dysfunction in bipolar disorder: results of a double-blind trialAlda, M. / MacQueen, G. M. / McKinnon, M. / Garnham, J. / MacLellan, S. / Hajek, T. / ODonovan, C. / Sokolenko, M. et al. | 2011
- S419
-
P.2.e.004 Quality of life in bipolar affective disorder in remission: clinical and personality correlatesElGhonemy, S. / Omar, A. N. / Essa, M. F. / Morsy, M. A. et al. | 2011
- S420
-
P.2.e.006 Sub -syndromal symptoms and time to episode recurrence in a naturalistic follow-up of bipolar disorder out-patientsDe Dios Perrino, C. / Terrazas, E. E. / Lopez, A. G. / Soler, B. / Aparicio, J. L. et al. | 2011
- S421
-
P.2.e.007 The impact of mood stabilisers on the emotionally modulated response inhibition in euthymic bipolar patientsNovak, T. / Sprah, L. / Tavcar, R. / Dernovsek, M. et al. | 2011
- S422
-
P.2.e.009 Morning serum cortisol during euthymia in bipolar 1 and 2 disorder compared with healthy controlsJohansson, A. G. / Landen, M. et al. | 2011
- S423
-
P.2.e.011 An open label pilot study of transcranial magnetic stimulation for patients with bipolar depressionKim, K. S. / Jung, E. J. et al. | 2011
- S425
-
P.2.e.014 Effects of magnetic seizure therapy in patients with treatment resistant depressionKayser, S. / Bewernick, B. H. / Lenz, D. / Hurlemann, R. / Soehle, M. / Schlaepfer, T. E. et al. | 2011
- S426
-
P.2.e.016 Biological correlates of the congruence and incongruence of psychotic symptoms in patients with type I bipolar disorderZumarraga, M. / Basterreche, N. / Davila, R. / Arrue, A. / Andia, I. / Gordo, E. / Davila, W. / Zamalloa, M. I. et al. | 2011
- S428
-
P.2.e.019 Efficacy of single ketamine infusion in bipolar depression: relationship with serum BDNFPermoda-Osip, A. / Adamski, R. / Bartkowska-Sniatkowska, A. / Chlopocka-Wozniak, M. / Skibinska, M. / Rybakowski, J. K. et al. | 2011
- S429
-
P.2.e.021 Vitamin D deficiency in schizophrenia, bipolar disorder and major depressive disorder compared to healthy controlsCha, B. / Shin, Y. M. / Kim, Y. S. / Kim, B. J. / Lee, C. S. / Sohn, J. W. / Park, C. S. et al. | 2011
- S430
-
P.2.e.022 Does shorter vs. longer stabilisation in patients with bipolar I disorder predict relapse?Vieta, E. / Bowden, C. L. / Masand, P. S. / Everitt, A. L. / Rahman, Z. / Marler, S. V. / Eudicone, J. M. / Baker, R. A. / Forbes, R. A. / Carlson, B. X. et al. | 2011
- S431
-
P.2.e.024 Bipolar I or II disorder patients in the course of a major depressive episode improve significantly with atypical antipsychotic treatmentSouery, D. / Audenaert, K. / Vankeirsbilck, A. / Vanlerberghe, T. et al. | 2011
- S432
-
P.2.e.026 Clinical, functional and therapeutic implications of comorbid personality disorders in a sample of bipolar patientsMurru, A. / Nivoli, A. M. / Pacchiarotti, I. / Popovic, D. / Vieta, E. / Colom, F. et al. | 2011
- S433
-
P.2.e.027 Supraphysiological doses of levothyroxine in bipolar depression: a randomised controlled, double blind studyStamm, T. / Adli, M. / Koeberle, U. / Pilhatsch, M. / Sauer, C. / Whybrow, P. / Frye, M. / Bauer, M. et al. | 2011
- S434
-
P.2.e.029 Lithium treated bipolar men have worse spatial working memory than womenSuwalska, A. / Gorna, K. / Jaracz, K. / Liczbinska, G. / Sobieska, M. / Rybakowski, J. K. et al. | 2011
- S436
-
P.2.e.032 Anxiety disorder comorbidity in patients with bipolar disorderToprak, E. / Karamustafalioglu, O. / Yavuz, B. G. / Bakim, B. / Ozer, O. et al. | 2011
- S437
-
P.2.e.034 Prevalence of adult attention deficit hyperactivity disorder in the relatives of patients with bipolar disorderTurkyilmaz, E. / Karamustafalioglu, O. / Yavuz, B. G. / Bakim, B. / Ozer, O. A. et al. | 2011
- S438
-
P.2.f.001 Decrease of lipid peroxidation in prefrontal cortex and hippocampus by alpha lipoic acid in an animal model of maniaCordeiro, R. C. / dos Santos, J. V. / Medeiros, C. D. / Morais, T. A. / Vasconcelos, S. M. / Sousa, F. C. / Macedo, D. S. / Carvalho, A. F. et al. | 2011
- S440
-
P.2.g.001 Difference between morning and evening thyrotropin-releasing hormone (TRH) tests could predict antidepressant responseDuval, F. / Mokrani, M. C. / Gonzalez, F. / Alexa, C. / Rabia, H. / Kazantseva, K. et al. | 2011
- S441
-
P.2.g.003 Efficacy of adjunct quetiapine extendedrelease in major depressive disorder: a pooled analysis of SSRI and SNRI patient subgroupsBauer, M. / Demyttenaere, K. / El-Khalili, N. / Thase, M. / Papakostas, G. I. / Szamosi, J. / Earley, W. / Eriksson, H. et al. | 2011
- S443
-
P.2.g.006 Influence of interferon-alpha therapy in patients with hepatitus C virus infection on phenylalanine metabolismZoller, H. / Anna, S. / Schroecksnadel, S. / Wolfgang, V. / Fuchs, D. et al. | 2011
- S444
-
P.2.g.008 Mapping structural impact of Val66Met BDNF genotype in melancholic depression: influence on time to clinical remissionSoria, V. / Cardoner, N. / Gratacos, M. / Hernandez-Ribas, R. / Via, E. / Pujo, J. / Urretavizcaya, M. / Estivill, X. / Menchon, J. M. / Soriano-Mas, C. et al. | 2011
- S445
-
P.2.g.009 Early antidepressant response of deep brain stimulation for depression treatment: a translational studyPerez-Caballero, L. / Perez-Egea, R. / Puigdemont, D. / Molet, J. / Mico, J. A. / Perez, V. / Berrocoso, E. et al. | 2011
- S446
-
P.2.g.011 The level of aggression among psychiatristsKozmin, A. / Kowalska, A. / Szczegielniak, A. / Wydra, K. / Debska, E. / Frey, P. / Krysta, K. et al. | 2011
- S447
-
P.2.g.013 Vagus nerve stimulation in depression: good for mood and bad for sleepSchmid, D. A. / Turk, A. / Zahn, F. / Keck, M. E. / Ropohl, A. et al. | 2011
- S448
-
P.2.g.015 Escitalopram vs duloxetine in major depressed patients with painBaloescu, A. / Baloescu, V. / Sichitiu, J. et al. | 2011
- S450
-
P.2.g.018 Psychopharmacotherapy of emotional burnout and depression among oncology staffVasylyeva, A. et al. | 2011
- S451
-
P.2.h.001 The phospholipase C inhibitor U73122 inhibits the in vitro and in vivo activity of the novel anxiolytic and antidepressant compound BNC210OConnor, S. / Wagner, S. / Huyard, B. / Kremmidiotis, G. / Andriambeloson, E. et al. | 2011
- S452
-
P.2.h.003 Do high dose antidepressants exacerbate psychosis? A case report from an early intervention serviceGillett, A. / Vecchio, D. et al. | 2011
- S453
-
P.3.a.001 Somatic comorbidity and schizophreniaBegic, D. / Bise, S. / Kurtovic, B. / Cemalovic, O. et al. | 2011
- S454
-
P.3.a.003 Abnormal local and long-range functional connectivity in schizophrenia during ultimatum gameYang-Tae, K. / Kyongsik, Y. / Jaeseung, J. et al. | 2011
- S455
-
P.3.a.005 Prevalence of pain and its correlation to depression: a cross-section study in major depressive patientsManeeton, N. / Maneeton, B. / Srisurapanont, M. et al. | 2011
- S457
-
P.3.a.008 Longitudinal proton magnetic resonance spectroscopy study in first-episode schizophreniaGalinska-Skok, B. / Szulc, A. / Tarasow, E. / Kubas, B. et al. | 2011
- S458
-
P.3.a.010 First-episode acute and transient psychotic disorder: 6 year follow-up in outpatient care departmentRusaka, M. / Rancans, E. et al. | 2011
- S459
-
P.3.a.012 Age of onset of schizophrenia and outcomes in 29 placebo-controlled RCTs of antipsychotics in the NEWMEDS repositoryRabinowitz, J. / Werbeloff, N. / Karayal, O. N. / Caers, I. / Kapur, S. et al. | 2011
- S460
-
P.3.a.013 Prevalence of restless legs syndrome and its correlates in schizophrenic inpatientsYoon, B. / Choi, H. / Park, S. / Pac, J. et al. | 2011
- S461
-
P.3.a.015 A poorer metabolic profile in subjects with early psychosis is associated with a distinct diurnal pattern in salivary cortisolOrtega, L. / Monseny, R. / Lopez, X. / Duch, M. / Valero, J. / Franch, J. / Walker, B. R. / Reynolds, R. M. / Labad, J. et al. | 2011
- S463
-
P.3.a.018 Attributional style moderates the relationship between duration of untreated psychosis and clinical symptoms: a longitudinal study in psychosisAlonso, M. / Garcia, A. / Ugarte, A. / Eguiluz, J. I. / Segarra, R. / Haidar, K. / Pena, J. / Ballorca, Y. / Martin, L. / Gutierrez, M. et al. | 2011
- S465
-
P.3.b.001 Cognitive impairment and formal thought disorders in adolescent schizophrenia spectrum patients and their parentsRemberk, B. / Namyslowska, I. et al. | 2011
- S466
-
P.3.b.003 Decreased serum DNase I activity in patients with schizophreniaDjordjevic, V. / Lazarevic, D. / Cosic, V. / Jevtovic-Stoimenov, T. / Djordjevic, V. B. et al. | 2011
- S468
-
P.3.c.002 Structured relaxation in the treatment of akathisia: case seriesHansen, L. / LAllemand, T. / Thiry, F. / Baldwin, D. et al. | 2011
- S469
-
P.3.c.004 Impact of addiction on cognitive and social functioning in one of twin brothers suffering from schizophreniaKrysta, K. / Krupka-Matuszczyk, I. / Janas-Kozik, M. / May-Majewski, A. / Skalbania, W. et al. | 2011
- S470
-
P.3.c.006 Metformin for weight loss in schizophrenia patients taking atypical antipsychoticsCho, D. / Je, H. et al. | 2011
- S471
-
P.3.c.007 Excitatory amino acids serum levels affected by antipsychotics in patients with schizophreniaHons, J. / Zirko, R. / Vasatova, M. / Cermakova, E. / Libiger, J. et al. | 2011
- S472
-
P.3.c.009 Predominant clinical dimension and acute treatment response in schizophrenic inpatientsBuoli, M. / Serati, M. / Caldiroli, A. / Altamura, A. C. et al. | 2011
- S474
-
P.3.c.012 The influence of antipsychotics on the occurrence of the metabolic syndrome in schizophrenic patientsSlavkovic, V. / Golubovic, S. T. / Zikic, O. / Gugleta, D. et al. | 2011
- S475
-
P.3.c.014 Antiepileptics ameliorated acute psychosis in a patient with Klinefelters syndromeMizuno, T. et al. | 2011
- S477
-
P.3.c.017 Effectiveness and tolerability of olanzapine long-acting injection versus first-generation depot for schizophrenia: clinical outcomesParise, V. F. / Balletta, G. / Addeo, L. / Foti, M. G. et al. | 2011
- S478
-
P.3.c.019 Risk of pathological decrease of bone mineral density in patients on parenteral risperidone long-term treatmentMarin, R. / Lozano, R. / Vazquez, M. D. / Santacruz, M. J. / Sebastian, F. / Pascual, A. / Lozano, A. et al. | 2011
- S479
-
P.3.c.020 Impact of antipsychotic dosage and polypharmacy on general cognitive abilities in patients with psychotic disordersNieto, L. / Cobo, J. / Pousa, E. / Domenech, C. / Severino, G. / Monreal, J. A. / Garcia-Pares, G. / Palao, D. et al. | 2011
- S480
-
P.3.c.022 Physical health problems in patients with severe mental illness: relationship between antipsychotic treatment and physical healthNayrouz, S. / Ploumaki, S. / Farooq, R. / Stock, D. / Lim, H. et al. | 2011
- S481
-
P.3.c.024 Comparison of perospirone and aripiprazole: a 12 weeks, randomised, open-label study in Japanese schizophrenia patientsTakekita, Y. / Kato, M. / Sakai, S. / Suwa, A. / Okugawa, G. / Kinoshita, T. et al. | 2011
- S482
-
P.3.c.026 Atypical antipsychotics on the improvement of depressive symptoms in the major depressive disorderPark, H. W. / Han, D. H. / Kim, S. M. / Lee, H. J. / Na, C. / Min, K. J. / Baek, H. T. et al. | 2011
- S483
-
P.3.c.027 Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot studyLee, J. G. / Kim, J. G. / Park, S. W. / Kim, Y. H. et al. | 2011
- S484
-
P.3.c.029 High levels of triglycerides in schizophrenic patients with quetiapine treatment: case seriesBragau, M. / Mosescu, M. D. / Popescu, A. / Rotaru, A. et al. | 2011
- S486
-
P.3.c.032 Spectrum of middle-mass endotoxic molecules and antibodies to DNA in schizophrenia patients with tardive dyskinesiaIvanova, A. S. / Smirnova, L. P. / Semke, A. V. / Ivanova, S. A. et al. | 2011
- S487
-
P.3.c.034 Efficacy of tadalafil on erectile dysfunction in male patients using antipsychotics: a double-blind placebo controlled cross-over trialde Boer, M. K. / Oolders, H. / Schoevers, R. A. / Wiersma, D. / Knegtering, H. et al. | 2011
- S488
-
P.3.c.035 Differential effects of aripiprazole versus risperidone on sexual performance, negative symptoms or emotional flatness (anhedonia)de Boer, M. K. / Liemburg, E. J. / Wiersma, D. / Schoevers, R. A. / Knegtering, H. et al. | 2011
- S489
-
P.3.c.037 Comparison of the efficacy and safety of amisulpride versus low-dose amisulpride plus low-dose sulpiride in treatment of schizophreniaLin, S. C. / Wang, F. C. / Huang, Y. H. / Lin, C. H. / Chen, C. C. et al. | 2011
- S490
-
P.3.c.039 Sustained treatment response in schizophrenia to JNJ-37822681 can be predicted within three daysAnghelescu, I. / Janssens, L. / Kent, J. / de Boer, P. / van Osselaer, N. / Tritsmans, L. / Daly, E. J. / van Nueten, L. / Schmidt, M. E. et al. | 2011
- S492
-
P.3.c.042 Tardive dyskinesia and cytochrome P450 1A2 gene polymorphism in Russian patients with schizophreniaGavrilova, V. / Filipenko, M. L. / Rudikov, E. V. / Semke, A. V. / Govorin, N. V. / Hadithy, A. F. / Loonen, A. J. / Ivanova, S. A. et al. | 2011
- S493
-
P.3.c.044 Atypical antipsychotics versus first generation antipsychotics: comparison of overall efficacy and costs in a Portuguese sampleGarrido, P. / Pereira, C. / Craveiro, A. et al. | 2011
- S495
-
P.3.c.047 Comorbidity in hospitalised psychotic patients treated with antipsychoticsMahia, M. G. / Fernandez, E. R. / Millares, M. V. et al. | 2011
- S496
-
P.3.c.049 Risk of adverse health outcome and metabolic syndrome in adolescents treated with antipsychotics: preliminary resultsMerchan-Naranjo, J. / Giraldez-Quiroga, M. / Moreno, C. / Pina, L. / Parellada, M. / Tapia, C. / Rodriguez, P. / Arango, C. et al. | 2011
- S497
-
P.3.c.050 Antipsychotic monotherapy versus polypharmacy in patients with serious mental illnessNtounas, P. / Tsopelas, C. / Konsta, A. / Rizos, E. / Diakoumopoulou, A. / Gkikas, P. / Siouti, E. / Touloumis, C. / Douzenis, A. / Lykouras, L. et al. | 2011
- S498
-
P.3.c.052 Fatal poisonings with phenothiazine-derivatives in the forensic toxicology practice: analysis of 143 casesSkowronek, R. / Celinski, R. / Krzystanek, M. / Korczynska, M. / Kulikowska, J. / Nowicka, J. / Chowaniec, C. et al. | 2011
- S499
-
P.3.c.054 Crossover comparison of serum glycemia variability of intramuscular forms of antipsychotics: aripiprazole, olanzapine and ziprasidoneLoza, B. / Patejuk-Mazurek, I. / Polikowska, M. / Bednarski, P. / Mosiolek, A. / Kwasna, J. / Grzesiewska, J. / Wojcik, R. / Wnukiewicz, P. / Mierzejewski, P. et al. | 2011
- S501
-
P.3.c.057 Prevalence of hyperprolactinemia and sexual dysfunction in patients with serious mental illnessNtounas, P. / Tsopelas, C. / Rizos, E. / Konsta, A. / Dimitraka, M. / Siouti, E. / Touloumis, C. / Douzenis, A. / Lykouras, L. et al. | 2011
- S502
-
P.3.c.059 Incidence, onset, and duration of treatment-emergent somnolence with asenapine in adult patients with schizophrenia or bipolar disorderSzegedi, A. / Cazorla, P. / Zhao, J. et al. | 2011
- S503
-
P.3.c.061 Treatment retention in a severe mentally illness programme: role of long acting atypical antipsychoticsFernandez-Miranda, J. J. / Gancedo-Alvarez, I. / Carames-Garcia, V. / Sanchez-Garcia, A. et al. | 2011
- S505
-
P.3.c.064 Concomitant psychotropic medications in the treatment of schizophrenia: a longitudinal perspectiveShinfuku, M. / Uchida, H. / Tsutsumi, C. / Suzuki, T. / Watanabe, K. / Tsutsumi, Y. / Kapur, S. et al. | 2011
- S506
-
P.3.d.001 Development of novel antipsychotic drugs based on olanzapine that display reduced weight gain and metabolic side effectsJafari, S. / Fernandez, F. / Huang, X. F. et al. | 2011
- S507
-
P.3.d.003 The cdk5 cofactor p35 is reduced in schizophrenia postmortem brains: downregulation of cdk5/p35/p25 after antipsychotic medicationRamos-Miguel, A. / Meana, J. J. / Garcia-Sevilla, J. A. et al. | 2011
- S508
-
P.3.d.005 Treatment of acute olanzapine-induced glucose dysregulation in rats: oral administration of metformin, rosiglitazone and glyburideBoyda, H. / Procyshyn, R. M. / Hawkes, E. / Li, J. / Jin, H. / Lo, C. / Xu, J. / Pang, C. C. / Honer, W. G. / Barr, A. M. et al. | 2011
- S510
-
P.3.d.008 The nitrinergic mediation of the antipsychotic-like effects of myricitrinPereira, M. / Siba, I. P. / Chioca, L. R. / Pizzolatti, M. G. / Santos, A. R. / Andreatini, R. et al. | 2011
- S511
-
P.3.d.010 Investigation of antagonist unbinding from dopamine D2 receptors using a real-time ion channel activation assaySahlholm, K. / Frisk, S. / Fuxe, K. / Arhem, P. et al. | 2011
- S512
-
P.3.e.001 Efficacy and tolerability of sodium valproate versus lithium carbonate in schizoaffective disorderSulejmanpasic, G. A. / Fisekovic, S. / Ler, S. / Frenjo, A. et al. | 2011
- S513
-
P.3.e.003 Improvement among male schizophrenic patients on clozapine and risperidone therapySibinovic, V. / Selimovic, G. / Tosic-Golubovic, S. / Mladenovic, T. et al. | 2011
- S514
-
P.3.e.004 Improving wellness and metabolic health in mental health consumers: a four-year naturalistic studyShriqui, C. / Lachance, I. / Bonneville, S. et al. | 2011
- S515
-
P.3.e.006 Nicotine effects on attention in schizophrenia: a simultaneous EEG-fMRI studyMobascher, A. / Warbrick, T. / Brinkmeyer, J. / Musso, F. / Stoecker, T. / Shah, N. J. / Vossel, S. / Winterer, G. et al. | 2011
- S516
-
P.3.e.008 Treatment adherence in schizophrenia using risperidone long-acting injectable: as early as possible, as long as possibleViala, A. / Boulicot, V. / Merlot, A. / Pinede, D. / Vacheron, M. N. et al. | 2011